呼吸器疾患のピットフォール

出版社： 呼吸研究(旧：レスピレーションリサーチファンデーション）
著者：
発行日： 2014-12-31
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784990729431
電子書籍版： 2015-01-01 （初版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,850 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

1,925 円(税込)

購入する

目次

  • 呼吸器疾患のピットフォール

    ―目次―

    1．感染
    2．腫瘍・腫瘍関連
    3．アレルギー・免疫的機序
    4．外的要因
    5．外傷
    6．先天性
    7．解剖構造の変化（種々の原因による）
    8．呼吸器・神経系機能異常
    9．他臓器疾患の併存
    10．その他

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 感染

P.6 掲載の参考文献
1) 小野譲. 気管支結核. 日結 11 : 171-1 76, 1952
 
2) 小松彦太郎 草なぎ芳明 倉島篤行. 気管支結核の臨床像および気管支鏡所見について. 気管支学 4 : 345-352, 1982
 
3) 豊田恵美子 工藤宏一郎 小林信之ほか. 気管・気管支結核の臨床的問題点. 気管支学 23 : 347-351, 2001
Medical*Online
4) 倉澤卓也 久世文幸 川合満ほか. 気管支結核症の重症度分類. 気管支学 12 : 157-166, 1990
 
5) 力丸徹 田中泰之 市川洋一郎ほか. 気管支結核症における治癒過程の検討-治癒過程の内視鏡分類の検討. 日胸疾会誌 31 : 426-430, 1993
 
6) 田村厚久 小松彦太郎 蛇澤晶ほか, 気管支結核の形態による分類 : 気管支鏡所見と病理所見の対比から. 気管支学 19 : 369-374, 1997
 
7) 荒井他嘉司. 気管支結核の新しい気管支鏡所見分類の有用性について. 気管支学 23 : 352-360, 2001
Medical*Online
8) 中島由槻 白石裕治. 結核性気管・気管支狭窄の外科治療とステント療法. 結核 74 : 897-905, 1999
 
9) 田村厚久 蛇澤晶 益田公彦ほか. 気管支結核の現状-103例の解析-. 結核 82 : 647-654, 2007
 
10) Tamura A, Higaki N, Kusaka K, et al, Doctor's delay in endobronchial tuberculosis. 結核 88 : 1-9, 2013
 
11) 横田総一郎 三木啓資. 気管支結核症に対するINH (イソニアジド) 吸入療法の効果. 結核 74 : 873-877, 1999
 
12) 力丸徹 大泉耕太郎. 気管支狭窄に対するストレプトマイシンとステロイド併用吸入療法の検討. 結核 74 : 879-883. 1999
 
13) 山田憲隆 垂水修 中川拓ほか. 当院における気管気管支結核に対するmPSL治療の臨床的検討. 気管支学 27 : 187, 2005
Medical*Online
14) Park IW, Choi BW. Hue SH Prospectlve study corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults. Respirology 2 : 275-281, 1997
PubMed
15) 青木正和. 医療機関における結核のリスクマネージメント. 結核 81 : 27-34, 2006
 
16) 垂井愛 大島信治 田村厚久ほか. 気管支結核におけるvirtualbronchoscopyおよび3-D CTの有用性の検討. 結核 83 : 335, 2008
 
P.11 掲載の参考文献
1) Littman ML, Borok R. Relation of pigeon to cryptococcosis : natural carrier state, heat resistance and survival of Cryp tococous neoformans. Mycopathologia 35 : 329-345, 1968
 
2) Casadevall A, Perfect JR. In : Cryptocoocus neoformans, ASM Press. Washington DC : 1999
 
3) Verstin K, May RC. Cryptococcal Interaction with the host immune system. Eukaryot Cell 9 : 835-846, 2010
 
4) 深在性真菌症のガイドライン作成委員会, 編. 深在性真菌症の診断・治療のガイドライン 2014, 協和企画. 東京 : 2014
 
5) Perfect JR, et al. Clinlcal Practice Guidelines for the Management of Cryptococcal Disease. 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 50, 291-322, 2010
 
6) Husain S, Wagener MM, Singh N. Cryptococcus neoformans Infection in organ transplant recipients : variables influencing clinical characteristics and outcome, Emerg Inect Dis 7 : 375-381, 2001
 
7) Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ traplantrecipients : an overview. Am J Transplant 2 : 575-580, 2002
PubMed
8) Baddley JW, Perfect JR, Oster RA, et al. Pulmonary crypcococcosis in patients without HIV infection : factor associated with disseminated disease, Eur J Clin Microbiol Infect Dis 27 : 937-943, 2008
PubMed
9) Galanis E, Macdougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis 16 : 251-257, 2010
PubMed
10) 国立感染症研究所ホームページ, 真菌情報高病原性クリプトコックス症 (Oryptococcus gattiiによるクリプトコックス症 : ガッティ型クリプトコックス症) に関する注意
 
11) Okamoto K, Hatakeyama S, Itoyama S, et al. Cryptococcus gattii Genotype VGIIa Infection in Man, Japan, 2007. Emerg Infect Dis 16 : 1155-1157, 2010
PubMed
P.16 掲載の参考文献
1) 金沢裕. Chlamydia psittaci感染症. オウム病の臨床. 臨床と微生 18 : 729-738, 1991
 
2) 岸本寿男 小川基彦 蔡燕ほか. オウム病呼吸 22 (1) : 38-44, 2003
 
3) 桑原正雄 光藤幸和 胤森信宏ほか. オウム病36例の臨床検討. 感染症誌 64 : 498-503, 1990
 
4) 斉藤美和子 新妻一直. 急性呼吸不全を呈した家族内発症のオウム病の2例. 日本胸部臨床 61 : 64-68, 2002
 
5) 神田慎太郎 山本洋 堀内俊道ほか. 家族内発症したオウム病の2例. 日呼吸会誌 45 : 253-257, 2007
 
6) 蝶名林直彦 中谷龍王 大谷真喜子ほか. 呼吸管理により救命でき, クラミジアを分離同定しえた重症オウム病の1例. 日胸疾会誌 27 : 357-366, 1989
 
7) 副島林造 窪田好史. クラミジア, 呼吸器感染症. 臨床と微生物 21 : 71-79, 1994
 
8) 大野勲 小西一樹. クラミジア C. psittaci, C. trachomatis, C. pneumoniae. 化学療法の領域 13 : 77-84, 1997
 
9) McGavran MH, Beard WC, Berendt RF, et al. The pathogenesis of sittacosis. Am J Pathol 40 : 653-661, 1962
 
10) Tuazon CU, Murray HW. Aypical pneumonias. In : Pennington JE ed. Respiratory Infections : Diagnosis and management, 3rd ed, Raven Press, New York : pp407-434, 1994
 
11) 副島林造 岸本寿男 中島正光ほか, クラミジア感染症. 化学療法の領域 11 : 1097-1108, 1995
 
12) 伊藤功朗 石田直 橋本徹ほか. Chlamydia pneumoniae肺炎, オウム病, マイコプラズマ肺炎の臨床的比較. 日呼吸会誌 39 : 172-177, 2001
Medical*Online
13) 日本呼吸器学会. 呼吸器感染症に関するガイドライン, 成人市中肺炎診療ガイドライン : 2005
 
14) 岸本寿男, 感染症の話 オウム病 (psittacosis). Infectious Diseases Weekly Report Japan 45W : 45 : 12-14, 2001
 
P.20 掲載の参考文献
1) Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med 343 : 1715-1721, 2000
PubMed
2) Braman SS. Postinfectious cough : ACCP evidence-based clinical practice guidelines. Chest 129 : S138-146, 2006
 
3) 日本呼吸器学会咳蹴に関するガイドライン第2版作成委員会, 咳嗽に関するガイドライン第2版, 日本呼吸器学会. 東京 : 2012
 
4) Senzilet LD, Halperin SA, Spika JS, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 32 : 1691-1697, 2001
PubMed
5) Couzigou C, Flahault A, Is pertussis being considered as a cause of persistent cough among adults. Eur J Epidemiol 18 : 1013-1015, 2003
PubMed
6) Miyashita N, Fukano H, Yoshida K, et al. Ohlamydia pneumon1ae infection in adult patients with persistent cough. J Med Microbiol 52 : 265-269, 2003
 
7) Centers for Disease Control and Prevention, Council of State and Territorial Epidemiologists. Pertussis-1997 case definition : 1997
 
8) World Health Organization. Pertussis-recommended case definition : 2002
 
9) Hewlett EL, Edwards KM. Clinical practice. Pertussis-not for kids, N Engl J Med 352 : 1215-1222, 2005
 
10) von Konig CH, Halperin S, Rifflmann M, et al. Pertussis of adults and infants. Lancet Infect Dis 2 : 744-750, 2002
 
11) Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults. Minnesota, 1995-1996. J Infect Dis 183 : 1353-1359, 2001
PubMed
12) Dragsted DM, Dohn B, Madsen J, et al. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol 53 : 749-754, 2004
PubMed
13) Sotir MJ, Cappozzo DL, Warshauer DM, et al. Evaluation of polymeraze chain reaction and culture for diagnosis of pertussis in the control of a country-wide outbreak focused among adlescents and adults. Clin Infect Dis 44 : 1216-1219, 2007
 
14) Kamachi K, Toyoizumi-Ajisaka H, Toda K, et al. Development and evaluation of a loop-mediated isothermal amplification method for rapid diagnosis of Bordetella pertussis infection, J Clin Microbiol 44 : 1899-1902, 2006
PubMed
15) 岡田賢司 蒲池一成 野上裕子ほか. 成人持続咳嗽 (2週間以上) 患者におけるLAMP法による百日咳菌抗原遺伝子陽性率と臨床像. 国立感染症研究所病原微生物検出情報 29 : 75-77, 2008
 
16) Snow V, Mottur-Pilson C, Gonzales R, et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 134 : 518-520, 2001
PubMed
17) Pillay V, Swingler G. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev Issue 4 : CD003257, 2003
PubMed
18) Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults, N Engl J Med 353 : 1555-1563, 2005
PubMed
P.24 掲載の参考文献
1) Southwick FS. Infectious diseases in 30 days. In : South-wick FS, ed. McGraw-Hill : pp467-472, 2003
 
2) Tunbridge AJ, Breuer J, Jeffery KJM, et al. Chickenpox in adults-Clinical management. Journal of Infection 57 : 95-102, 2008
PubMed
3) Breuer J. Varicella zoster. In : Principles and Practice of Clinical Virology, 5th ed, Wiley. West Sussex : pp 53-84, 2004
 
4) 斧原康人 古西満 濱田薫ほか. 気管支病変を認めた成人水痘肺炎の1例. 日胸疾会誌 33 : 74-78, 1995
 
5) Alanezi M. Varicella pneumonia in adults : 13 years experience with review of literature. Annals of Thoracic Medicine 2 : 163-165, 2007
PubMed
6) Feldman S, Lott L. Varicella in chiidren with cancer : impact of antiviral therapy and prophylaxis. Pediatrics 80 : 465-472, 1987
 
7) Mohsen AH, McKendric M. Varicella pneumonia in adults. Eur Respir J 21 : 886-891, 2003
 
8) Kim JS, Ryu CW, Lee SI, et al. High-resolution CT findings of varicella-zoster pneumonia. AJR 172 : 113-116, 1999
PubMed
9) 串間尚子 水之江俊治 橋永一彦ほか. 気管支粘膜病変を認めた成人水痘肺炎の1例. 日胸 65 : 1125-1129, 2006
Medical*Online
P.28 掲載の参考文献
1) MacMillan JC, Milstein SH, Samson PC. Clinicalspectrum of septic pulmonary embolism and infarction. J Thorac Cardiovasc Surg 75 : 670-679, 1978
 
2) 武田英紀 後藤元. 敗血症性肺塞栓症. 日本臨床別冊 (呼吸器症候群 II) : 330-335, 2009
 
3) Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am Heart J 117 : 1140-1146, 1989
PubMed
4) 武田英紀 後藤元. 敗血症性肺塞栓症. Geriatr Med 43 : 1785-1790, 2005
 
5) Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1 : 701-703, 1936
 
6) Cook RJ, Ashton RW, Aughenbaugh GL, et al. Septic pulmonary embolism : presenting features and clinical course of 14 patients. Chest 128 : 162-166, 2005
PubMed
7) Jaffe RB, Koschmann EB, Septic pulmonary emboli. Radiology 96 : 527-532, 1970
PubMed
8) Lee SJ, Cha SI, Kim CH, et al. Septic pulmonary embolism in Korea : microbiology, clinicoradiologic features, and treatment outcome. J Infect 54 : 230-234, 2007
PubMed
9) Zelefsky MN, Lutzker LG. The target sign : a new radiologic sign of septic emboli. Am J Roentgenol 129 : 453-455, 1977
 
P.33 掲載の参考文献
1) Estrera AS, Landay MJ, Grisham JM, et al. Descending necrotizing mediastinitis. Surg Gynecol Obstet 157 : 545-552, 1983
PubMed
2) Wheatley MJ, Stirling MC, Kirsh MM, et al. Descending necrotizing mediastinitis : Transcervical drainage is not enough. Ann Thorac Surg 49 : 780-784, 1990
 
3) Freeman RK, Vallieres E, Verrier ED, et al, Descending necrotizing mediastinitis : An analysis of the effects of serial surgical debridement on patient mortality. J Thofiac Cardiovasc Surg 119 : 260-267, 2000
PubMed
4) Makeieff M, Gresillon N, Berthet JP, et al. Management of descending necrotizing mediastinitis. Laryngoscope 114 : 772-775, 2004
PubMed
5) Roccia F, Pecorari GC, Oliaro A, et al. Ten years of descending necrotizing mediastinitis : management of 23 cases, J Oral Maxillofac Surg 65 : 1716-1724, 2007
 
6) 茂木充 高柳昇 柳沢勉ほか. 扁桃周囲膿瘍に続発した降下性壊死性縦隔炎の1例 : 本邦報告35例の集計. 日胸臨 58 : 127-133, 1999
 
7) Marty-Ane CH, Alauzen M, Alric P, et al. Descending necrotizing mediastinitis : Advantage of mediastinal drain-age with thoracotomy. J Thorac Cardiovasc Surg 107 : 55-61, 1994
 
8) Brunelli A, Sabbatini A, Catalini G, et al. Descending necrotizing mediastinitis : Surgical drainage and tracheostomy. Arch Otolaryngol Head Neck Surg 122 : 1326-1329, 1996
PubMed
9) Becker M, Zbaren P, Hermans R, et al. Necrotizing fasciitis of the head and neck : Role of CT in diagnosis and management. Radiology 202 : 471-476, 1997
PubMed
10) Marty-Ane CH, Berthet JP, Alric P, et al. Management of descending necrotizing mediastinitis : An aggressive treatment for an aggressive disease. Ann Thorao Surg 68 : 212-217, 1999
 
11) Misthos P, Katsaragakis S, Kakaris S, et al. Descending necrotizing anterior mediastinitis : Analysis of survivai and surgical treatment modalities. J Oral Maxillofec Surg 65 : 635-639, 2007
 
12) Endo S, Murayama F, Hasegawa T, et al. Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg 47 : 14-19, 1999
PubMed
13) Roberts JR, Smythe WR, Weber RW, et al. Thoracoscopic management of descending necrotizing mediastinitis. Chest 112 : 850-854, 1997
PubMed
14) Min HK, Choi YS, Shim YM, et al, Descending necrotizing mediastinitis : A minimally invasive approach using video-assisted thoracoscopic surgery. Ann Thorac Surg 77 : 306-310, 2004
PubMed
15) Chen KC, Chen JS, Kuo SW, et al. Descending necrotizing mediastinitis : A 10-year surgical experience in a single institution. J Thorac Oardiovasc Surg 136 : 191-198, 2008
 
16) Ris HB, Banic A, Furrer M, et al. Descending necrotizing mediastinitis : Surgical treatment via clamshell approach. Ann Thorao Surg 62 : 1650-1654, 1996
 
17) Casanova J, Bastos P, Barreiros F, et al. Descending necrotizing mediastinitis : Successful treatment using a radical approach. Eur J Cardiothorac Surg 12 : 494-496, 1997
PubMed
18) Papilla E, Rena O, Oliaro A, et al. Descending necrotizing mediastinitis : Surgical manaegement. Eur J Cardiothorac Surg 20 : 739-742, 2001
 
19) Van Straalen HCM, Jansveld KAF, Michels LFE, et al. Mediastinitis with fistula formation to the left main bronchus : A complication of wisdom tooth extraction. Chest 106 : 623-624, 1994
 
20) Kato H, Ohkubo N, Akazawa K, et al. Spontaneous closure of a large tracheal fistula due to descending necrotizing mediastinitis. Ann Thorac Surg 69 : 1249-1251, 2000
PubMed
21) 深田穣治 稲岡正己. 右主気管支瘻を併発した降下性壊死性縦隔炎の1手術救命例, 日胸外会誌 44 : 529-533, 1996
 
22) Murakawa T, Yoshida Y, Fukami T, et al. Life-threatening tracheal perforation secondary to descending necrotizing mediastinitis. Interact Cardio Vasc Thorac Surg 10 : 454-456, 2010
 
23) Ichimura H, Ishikawa S, Hiramatsu Y, et al. Innominate artery rupture after transcervical drainage for descending necrotizing mediastinitis. Ann Thorac Surg 71 : 1028-1030, 2001
PubMed
24) Iwata T, Sekine Y, Shibuya K, et al. Early open thoracotomy and mediastinopleural irrigation for severe descending necrotizing mediastinitis. Eur J Cardiothorac Surg 28 : 384-388, 2005
PubMed
P.38 掲載の参考文献
1) http://www.jata.or.jp/rit/ekigaku/info/kaisetu/
 
2) 日本結核病学会, 編. 結核診療ガイドライン. 南江堂. 東京 : pp93, 2009
 
P.43 掲載の参考文献
1) Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res 135 : 703-730, 2012
PubMed
2) Sharma SK, Mohan A. Sharma A, Mitra DK. Miliary tuberculosis : new insights into an old disease. Lancet Infect Dis 5 : 415-430, 2005
 
3) Ray S, Talukdar A. Kundu S, Khanra D, Sonthalia N. Diagnosis and management of miliary tuberculosis : current state and future perspectives. Ther Clin Risk Manag 9 : 9-26, 2013
PubMed
4) 岩崎龍郎. 改訂 結核の病理. 日経印刷 : 1997
 
5) 蛇澤晶. 結核の病理 : 泉孝英, 監修, 結核. 医学書院. pp26-40, 2006
 
6) Fujita J, Bandoh S, Kubo A, Ishii T, Kanaji N, Nakamura H, Higa F, Tateyama M, Ishida T. HRCT shows variations in appearance in disseminated tuberculosis in adults. Int J Tuberc Lung Dis 10 : 222-226, 2006
PubMed
7) Matsushima T. Miliary tuberculosis or disseminated tuberculosis. Intern Med 44 : 687, 2005
 

II. 腫瘍・腫瘍関連

P.48 掲載の参考文献
1) Albrecht E. Uber Hamartome. Verh Dtschees Pathol 7 : 153-157, 1904
 
2) 塩沢正俊. 肺の過誤腫. 日胸外会誌 21 : 85-100, 1973
 
3) Hansen CP, Holtveg H, Francis D, et al. Pulmonary hamartoma. J Thorac Cardiovasc Surg 104 : 674-678, 1992
PubMed
4) van den Bosch JM, Wagenaar SS, Corrin B, et al. Mesenchymoma of the lung (so called hamartoma) : a review of 154 parenchymal and endobronchial cases. Thorax 42 : 790-793, 1987
PubMed
5) Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Clin Proc 71 : 14-20, 1996
PubMed
6) Cosio BG, Villena V, Echave-Sustaeta J, et al. Endobronchial hamaroma. Chest 122 : 202-205, 2002
 
7) 中谷貴美子 西岡明人 刈谷真爾ほか. 亜区域発生の気管支内過誤腫の1例 本邦報告115例の検討. 臨放 50 : 187-190, 2005
 
8) Ahn JM, Im JG, Seo JW, et al. Endobronchial hamartoma : CT findings in three patients. Am J Roentgenol 163 : 49-50, 1994
 
9) Gaerte SC, Meyer CA, Winer-Muram HT, et al. Fat-containing lesions of the chest. Radiographics 22 S61-78, 2002
PubMed
10) Li W, Ellerbroek NA, Libshitz HI. Primary malignant tumors of the trachea. A radiologic and clinical study. Cancer 66 : 894-899, 1990
PubMed
11) Seo JB, Im JG, Goo JM, et al. Atypical pulmonary metastases : spectrum of radiologic findings. Radiographics 21 : 403-417, 2001
PubMed
12) Cheu HW, Grishkin BA, Linville WK. Endobronchial hamartoma treated by bronchoscopic excision. South Med J 86 : 1164-1165, 1993
PubMed
13) 奥仲哲弥. レーザー療法の適応と限界. 気管支学 27 : 489-493, 1999
 
14) 井上祐一 山下祐子 仲宗根朝紀ほか. 高周波電流によりポリペクトミーを施行した気管支内過誤腫の1例. 気管支学 17 : 512-517, 1995
Medical*Online
P.52 掲載の参考文献
1) Albrecht E. Ueber Hamartome. Verh Dtsch Path Ges 7 : 153, 1904
 
2) Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Clin Proc 71 : 14-20, 1996
PubMed
3) Willis RA. The borderland of embryology and pathology, Butterworth. London : 1958
 
4) van den Bosch JM, Wagenaar SS, Corrin B, Elbers JR, Knaepen PJ, Westermann CJ. Mesenchymoma of the lung (so called hamartoma) : a revlew of 154 parenchymal and endobronchial cases. Thorax 42 : 790-793, 1987
PubMed
5) Tazelaar HD. Chapter 18 Uncommon Tumors of the Lung In : Churg AM, Myers JL, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. Thieme New York : 2005
 
6) Siegelman SS, Khouri NF, Scott WW Jr, et al. Pulmonary hamartoma : CT findings. Radiology 160 : 313-317, 1986
PubMed
7) Nicholson AG, Tomashefski JFJ, Hamartoma HP. World Health Organization Classification of Tumours. In : Travis WD, Brambilla E, HK M-H, Harris C, eds. Pathology & Genetics Tumours of the Lungs, Pleura, Thymus and Heart, IARC Press. Lyon : 2004
 
8) Takemura T, Kusafuka K, Fujiwara M, et al. An immunohistochemical study of the mesenchymal and epithelial components of pulmonary chondromatous hamartomas. Pathol Int 49 : 938-946, 1999
PubMed
9) Bateson EM. So-called hamartoma of the lung--a true neoplasm of fibrous conneCtive tissue of the bronchi. Cancer 31 : 1458-1467, 1973
 
10) Perez-Atayde AR, Seiler MW. Pulmonary hamartoma. An ultrastructural study. Canoer 53 : 485-492, 1984
 
11) Dunbar F, Leiman G, The aspiration cytology of pulmonary hamartomas. Diagn Cytopathol 5 : 174-180, 1989
PubMed
12) Kazmierczak B, Meyer-Bolte K, Tran KH, et al. A high frequency of tumors with rearrangements of genes of the HMGI (Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Ohromosomes Cancer 26 : 125-133, 1999
 
13) Tallini G, Vanni R, Manfioletti G, et al. HMGI-Cand HMGI (Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI (Y) genes. Lab Invest 80 : 359-369, 2000
 
14) Dahlen A, Mertens F, Rydholm A, et al. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16 : 1132-1140, 2003
PubMed
15) Fletcher JA, Pinkus GS, Donovan K, et al. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res 52 : 6224-6228, 1992
PubMed
16) Fletcher JA, Pinkus GS, Weidner N, Morton CC. Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 138 : 1199-1207, 1991
PubMed
17) Rodriguez FJ, Aubry MC, Tazelaar HD, Slezak J, Carney JA, Pulmonary chondroma : a tumor associated with Carney triad and different from pulmonary hamartoma. Am J Surg Pathol 31 : 1844-1853, 2007
PubMed
P.58 掲載の参考文献
1) 林田美江ほか. 特定疾患治療研究事業対象疾患 リンパ脈管筋腫症 (LAM) 認定基準の解説. 日本呼吸器学会雑誌 49 : 67-74, 2011
Medical*Online
2) 平間未知大 瀬山邦明. 重症の閉塞性換気障害を認めてもCOPDではないことがある. 内科 99 : 1116-1117, 2007
 
3) Rowan C, Hansell DM, Renzoni E, Maher TM, Wells AU, Polkey MI, Rehal PK, Ibrahim WH, Kwong GN, Colby TV, Pistolesi M, Bigazzi F, Comin CE, Nichoison AG. Diffuse cystic lung disease of unexpfiained cause with coexistent small airway dlsease : a possible causal relationship? Am J Surg Pathol 36 : 228-234, 2012
 
4) 原啓. シェーグレン症候群における肺のアミロイドーシスと嚢胞. 日本胸部臨床 68 : 311-322, 2009
Medical*Online
5) Franquet T, et al. Lung cysts in subacute hypersensitivity pneumonitis．J Comput Assist Tomogr 27 : 475-478, 2003
PubMed
6) Matsul K, et al. Prognostic significance of pulmonary lymphangiolelomyomatosis histologic score. Am J Surg Pathol 25 : 479-484, 2001
 
7) Watanabe M, et al. Pulmonary manifestations in Sjogren's syndrome : correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumtol 37 : 365-373, 2010
 
P.64 掲載の参考文献
1) 日本呼吸器学会びまん性肺疾患 診断・治療ガイドライン作成委員会, 編. 特発性間質性肺炎診断と治療の手引き (改訂第2版). 南江堂. 東京 : 2011
 
2) Aubry MC, Myers JL Douglas WW, et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis, Mayo Clin Proc 77 : 763-770, 2002
PubMed
3) Kawasaki H, Nagai K, Yoshida J, et al. Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. Surg Oncol 76 : 53-57, 2001
PubMed
4) Park J, Kim DS, Shim TS, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17 : 1216-1219, 2001
 
5) Jeon K, Chung MP, Lee KS, et al. Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis. Respir Med 100 : 451-457, 2006
PubMed
6) Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190 : 773-779, 2014
PubMed
7) Raghu G, Collard HR, Egan J, et al. An official ATS/ERS/JRS/ALAT statement : Idiopathic pulmonary fibrosis : Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011
PubMed
8) King TE Jr, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis : scoring system and survival model. Am J Respir Crit Care Med 164 : 1171-1181, 2001
PubMed
9) Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome, Ohest 141 : 222-231, 2012
PubMed
10) 小谷敬太 村田和子 吉田祥二. 肺気腫と特発性肺線維症の併存症例における胸部CT像の評価. 断映研会誌 31 : 25-29, 2004
 
11) Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema : a distinct underrecognised entity. Eur Respir J 26 : 586-593, 2005
PubMed
12) Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 15 : 265-271, 2010
PubMed
13) Usui K, Tanai C, Tanaka Y, et al. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer, Respirology 16 : 326-331, 2011
PubMed
14) 三好新一郎 門倉光隆 近藤晴彦ほか, 2008年度呼吸器外科手術統計. 日呼外会誌 25 : 124-132, 201L
 
15) Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer : Analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 126 : 1141-1146, 2003
PubMed
16) Kawasaki H, Nagai K, Yoshida J, et al. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 81 : 33-37, 2002
PubMed
17) 青山克彦 星永進 生方幹夫ほか. 肺癌の合併とその対応. 日胸 62 : S114-120, 2003
Medical*Online
18) Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 147 : 1604-1611, 2014
PubMed
19) 河端美則 青山克彦 星永進ほか. 肺癌切除肺のUsual Interstitial Pneumonia病変とその急性増悪の病理学的検討. 肺癌 45 : 115-121, 2005
Medical*Online
20) Saito H, Minamiya Y, Nanjo H, et al. Pathological finding of subclinical interstitial pneumonia as a predictor of postoperative acute respiratory distress syndrome after pulmonary resection. Eur J Cardiovasc Surg 29 : 190-194, 2011
 
21) 坂東政司. 間質性肺炎合併肺癌手術の合併症対策とそのエビデンスを教えてください : 弦間昭彦, 編. 肺癌診療 : こんなときどうする Q&A, 中外医学社, 東京 : 2011 (発刊直前)
 
22) 弦間昭彦. 特発性間質性肺炎合併進行肺癌の標準的化学療法に関する検討, 厚生労働省特定疾患びまん性肺疾患に関する調査研究 平成23年度びまん性肺疾患に関する調査研究報告書 : 181-186, 2011
 
23) Kenmotsu H, Naito T, Kimura M, et al. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 6 : 1242-1246, 2011
PubMed
24) 峯岸裕司 弦間昭彦. 特発性間質性肺炎合併進行期/術後再発肺癌の二次治療以降の化学療法に関する実態調査. 厚生労働省特定疾患びまん性肺疾患に関する調査研究平成25年度びまん性肺疾患に関する調査研究報告書 : 77-81, 2014
 
25) 村岡昌司 赤嶺晋治 土谷智史ほか. 胸部外科の指針 間質性肺炎合併肺癌の周術期ステロイドおよびerythromycin投与の有用性. 胸部外科 60 : 87] -878, 2007
 
26) Yamauchi Y, Izumi Y, Inoue M, et al. Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idniopathic pulmonary fibrosis. PLoS ONE 6 : e29053, 2011
PubMed
27) 坂東政司 杉山幸比古. IPF合併肺癌の術前リスク評価および術後合併症の予防対策. 日胸 70 : 784-795, 2011
Medical*Online
28) 青山克彦 金沢実 金子公一ほか. 肺線維化病変合併肺癌症例の術後急性増悪に対するステロイド予防投与. 臨呼吸生理 35 : 123- 126, 2003
 
P.67 掲載の参考文献
1) Bruce DM, et al. Lymphangitis carcinomatosa. a literature review. J R Coll Surg Edinb 41 : 7-13, 1996
PubMed
2) 伊地知佳世ほか. 癌性リンパ管症の診断と治療のすすめかた. Medical Practice 27 : 653-658, 2010
Medical*Online
3) 大江裕一郎. 癌性リンパ管症の診かた. 治療 85 : 1942-1946, 2003
Medical*Online
4) 大石修司ほか. 癌性リンパ管症. 総合臨床 52 : 1577-1580, 2003
Medical*Online
5) Johkoh T, et al. CT Findings in Lymphangitic Carcinomatosis of the Lung. Correlatin with Histobgic Findings and Pulmonary Function Tests. AJR 158 : 1217-1222, 1992
 
6) 佐藤隆ほか. 肺の癌性リンパ管症の臨床病理学的検討-その発生と進展様式-. 日胸疾会誌 26 : 1243-1248, 1988
 
7) Prakash P, et al. FDG PET/CT in Assessment of Plumonary Lymphangitic Crcinomatosis AJR 194 : 231-236, 2010
 
8) 小原弘之ほか. 進行肺癌患者の緩和治療-呼吸困難のコントロール-. 日胸 61 : 969-981, 2002
 
P.72 掲載の参考文献
1) Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44 : 565-601, 2000
PubMed
2) Jiang L, Akatsuka S, Nagal H. et al. Iron overload signature in chrysotile-induced malignant mesothelioma. J Pethol 228 : 366-377, 2012
 
3) Testa JR, Cheung M, Pei J, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43 : 1022-1025, 2011
PubMed
4) Whitaker D, Henderson DW, Shinkin KB. The concept of mesothelioma in situ : implications for diagnosis and histogenesis. Semin Diagn Pathol 9 : 151-161, 1992
 
5) Nakano T, Chahinian AP, Shinjo M, et al. Interleukin 6 and its relationship to Ckinical parameters in patients with malignant pleural mesothelioma. Br J Oancer 77 : 907-912, 1998
 
6) Fukuoka K, Kunbayashi K, Yamada S, et al. Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma. Mol Clin Oncol 1 : 942-948, 2013
 
7) Weder W, Stahel RA, Baas P, et al. The MARS feasibility trial : conclusions not supported by data. Lancet Oncol 12 : 1093-1094, 2011
 
P.77 掲載の参考文献
1) Creswell LL, Wells SA Jr. Mediastinal masses orlginating in the neck. Chest Surg Clin North Am 2 : 23-25, 1992
 
2) Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 58 : 356-383, 2010
PubMed
3) Wakeley CPG, Mulvany JH. Intrathoracic goiter. Surg Gynecol Obstet 70 : 702-710, 1940
 
4) Mora JM, et al. Posterior mediastinal goiter. Surg Gynecol Obstet 79 : 314-317, 1944
 
5) Rlves JD. Mediastinal aberrant goiter. Ann Surg 126 : 797-810, 1947
 
6) 正岡昭. 甲状腺腫mediastinal goiter : 呼吸器外科学, 南山堂, 東京 : pp418, 2009
 
7) Shields TW. Mediastinal Thyroid Tumors. In : Thoracic Surgery, 2nd ed. Elsevier Health Science : pp1748-1759, 2003
 
8) Cove H. The mediastinum. In : Coulson WF, ed Surgical Pathology, 2nd ed, JB Lippincott. Philadelphia : 1988
 
P.81 掲載の参考文献
1) Shimosato Y, Mukai K, Matsuno Y. Mediastinal cysts (other than thymic cyst). In : Silverberg SG, ed. Tumors of the Mediastinum. AFIP Atlas of Tumor Pathology. Fourth Series. ARP Washington, DC : pp305-308, 2010
 
2) Marchevsky AM, Kaneko M. Mediastinal cysts, In : Marchevsky AM, ed. Surgical Pathology of the Mediastinum. Raven. New York. pp217-234, 1984
 
3) 冨地信和 小野貞英 小野寺賢 石田格 大浦裕之 半田政志. 後縦隔に発生した気管食道嚢胞の1例 肺癌 52 (2) : 215-219, 2012
Medical*Online
4) Abell MR. Mediastinal cysts. Arch Pathot 61 : 360-379, 1956
PubMed
5) Hyoung UJ, Chung KS, Park YY, Lee KK. A case of tracheoesophageal cyst in the posterior mediastinum. Yonsei Med J 30 : 396-401, 1989
PubMed
6) Horwitz JR, Lally KP. Bronchogenic and esophageal duplication cyst in a single mediastinal mass in a child. Pediatr Pathol Lab Med 16 : 113-118, 1996
 
7) 竹川宏典 高岡和夫 藤岡保範. 1つの腫瘤として発生した縦隔食道気管支嚢胞の1症例. 日胸疾会誌 35 : 796-800, 1997
 
8) Lee S, Lee J, Park JH, Kim YW, Yang MH, Shin DW. Extralobar pulmonary sequestration with an associated cyst of mixed bronchogenic and esophageal type-a case report. JKMS 12 : 567-569, 1997
 
9) 梁川雅弘 富山憲幸. 縦隔の嚢胞性病変. 画像診断 29 : 1574-1584, 2009
 
10) Stocker JT. Bronchogenic cyst. In : Tomashefski TF, ed. Dail and Hammar's Pulmonary Pathology. Vol.1. 3rd ed. Springer. New York : pp142-144, 2008
 
P.86 掲載の参考文献
1) 本村政勝, 傍腫瘍性神経症候群 : 診断と治療の進歩 神経筋接合部の障害. 日本内科学会雑誌 97 (8) : 18-22, 2008
 
2) Anderson HJ, Churchill-Davidson HC, Richardson AT. Bronchial neoplasm with myasthenia-prolonged apnoea after administration of succinylcholine. Lancet 265 : 1291-1293, 1953
PubMed
3) Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 187 : 612-613, 1956
 
4) Titulaer MJ, Lang B, Verschuuren JJGM, Lambert-Eaton myasthenic syndrome : from clinical characteristics to theeapeutic strategies, Lancet Neurol 10 : 1098-1107, 2011
 
5) Lipka AF, Verschuuren JJ, Titulaer MJ. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma. Ann N Y Acad Sci 275 : 70-77, 2012
 
6) Nakao YK, Motomura M, Fukudome T, et al. Seronegative Lambert-Eaton myasthenic syndrome studey of 110 Japanese patients. Neurology 59 : 1773-1775, 2002
 
7) Delahunt B, Abernethy DA, Johnson CA, et al. Prostate carcinoma and the Lambert-Eaton myasthenic syndrome. J Uro 169 : 278-279, 2003
 
8) Morimoto M, Osaki T, Nagara Y, et al. Thymoma with Lambert-Eaton myasthenic syndrome. Ann Thorac Surg 89 : 2001-2003, 2010
PubMed
9) 阿保未来 市川聡裕 古川健治ほか. 経過中にLambert-Eaton症候群を呈した悪性リンパ腫の1例. 日内会誌 85 : 765-766, 1996
 
10) Maddison P, Newsom-Davis J, Mills KR, et al. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 335 (8703) : 1416-1418, 1990
 
11) Monstad SE, Drivsholm L, Storstein A, et al. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer, J Clin Oncol 22 (5) : 795-800, 2004
 
12) Payne M, Bradbury P, Lang B, et al. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer. J Thorao Oncol 5 (1) : 34-38, 2010
 
13) Wirtz PW, Lang B, Graus F, et al, P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in smallcell lung cancer. J Neuroimmunol 164 (1-2) : 161-165, 2005
 
14) Titulaer MJ, Wirtz PW, Willems LN, et al. Screening for small-cell lung cancer : a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Onool 26 (26) : 4276-4281, 2008
 
15) 金森斎修 八幡知之 大塚今日子ほか. Lambert-Eaton筋無力症候群を合併した原発部位不明の小細胞肺癌の1例. 日呼吸会誌 47 (12) : 1151-1155, 2009
Medical*Online
16) 中村さやか 河岸由紀男 加藤慎平ほか. 無治療で長期生存したLambert-Eaton症候群合併肺癌の1例. 日呼吸会誌 48 (12) : 918-922, 2010
 
17) 本村政勝. Lambert-Eaton筋無力症候群-本邦LEMS 110例の検討. 臨床神経 39 : 1237-1239, 1999
 
P.90 掲載の参考文献
1) Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15 (6) : 529-553, 1991
PubMed
2) 日本肺癌学会, 編. 日本肺癌学会 肺癌診療ガイドライン 肺癌の病理・細胞診断ガイドライン 2011年6月 (http://www.haigan.gr.jp/uploads/photos/321.pdf)
 
3) Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J 18 (6) : 1059-1068, 2001
PubMed
4) Asamura H, Kameya T, Matsuno Y, et al. Neuroendocrine neoplasms of the lung : a prognostic spectrum. J Clin Oncol 1 (24) : 70-76, 2006
 
5) Le Treut J, Sault MC, Lena H, et al. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma : the GFPC 0302 study. Annals of Oncology 24 (6) : 1548-1552, 2013
PubMed
6) Niho S, Kenmotsu H, Sekine I, et al. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung : a multicenter phase II study. J Thorac Onool 8 (7) : 980-984, 2013
 
7) Iyoda A, Hiroshima K, Moriya Y, et al. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg 132 (2) : 312-315, 2006
PubMed
8) Varlotto JM, Medford-Davis LN, Recht A, et al. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol 6 (6) : 1050-1058, 2011
PubMed
9) Iyoda A, Hiroshima K, Moriya Y, et al. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg 82 (5) : 1802-1807, 2006
PubMed
10) Fazio N, Granberg D, Grossman A, et al. Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors : analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study. Chest 143 (4) : 955-962, 2013
PubMed
11) Yanagisawa S, Morikawa N, Kimura Y, et al. Large-Cell Neuroendocrine Carcinoma with EGFR Mutation : Possible Transformation of Lung Adenocarcinoma. Respirology 17 (8) : 1275-1277, 2012
PubMed
P.96 掲載の参考文献
1) Calro MS, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases : an expert TLS panel consensus. Br J Haematol 149 (4) : 578-586, 2010
 
2) Howard SC, Jones DP. Pui CH. The tumor lysis syndrome. N Engl J Med 364 (19) : 1844-1854, 2011
 
3) Mott FE, et al. Tumor lysis syndrome in solid tumors. Support Cancer Ther 2 (3) : 188-191, 2005
PubMed
4) Gemici C. Tumour lysis syndrome in solid tumours. Clin Oncol (R Coll Radiol) 18 (10) : 773-780, 2006
PubMed
5) Goldman SC. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97 (10) : 2998-3003, 2001
PubMed
6) Cortes J, et al : Control of plasma uric acid in adults at risk for tumor Lysis syndrome : efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study. J Clin Oncol 28 (27) : 4207-4213, 2010
PubMed
7) Ishizawa K, et al. Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study. Cancer Sci 100 (2) : 357-362, 2009
 

III. アレルギー・免疫的機序

P.101 掲載の参考文献
1) Pang LG. Allergy of the larynx, trachea, and bronchial tree. Otolaryngol Clin North Am 7 : 719-734, 1974
 
2) 藤村政樹, 監修. 喉頭アレルギー. 前田書店, 東京 : 2006
 
3) 斉藤正治 内藤健晴 伊藤周史ほか. スギ花粉症の咽喉頭症状に対する塩酸オロパタジンによる初期療法の有用性. 診断と新薬 44 : 15-21, 2007
 
P.105 掲載の参考文献
1) Nishima S, Chisaka H, Fujiwara T, et al. Surveys on the prevalence of pediatric bronchial asthma in Japan : a comparison between the 1982, 1992, and 2002 surveys conducted in the same region using the same methodology. Allergol Int 58 : 37-53, 2009
PubMed
2) Martinez FD, et al. Asthma and wheezing in the first six years of life. N Engl J Med 332 : 133-138, 1995
PubMed
3) Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Resplr Crit Care Med 171 : 722-727, 2005
 
4) Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 114 : 1282-1287, 2004
PubMed
5) 足立雄一. 乳児喘息の実態, 診断, 治療. 日本小児アレルギー学会誌 20 : 27-32, 2006
Medical*Online
6) Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children. Eur Respir J 32 : 1096-1110, 2008
PubMed
7) Sonnappa S, Bastardo CM, Wade A, et al. Symptompattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol 126 : 519-526, 2010
PubMed
8) Schultz A, Devadason SG, Savenije OE, et al. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 99 : 56-60, 2010
PubMed
9) Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 354 : 1998-2005, 2006
PubMed
10) Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 : 1985-1997, 2006
PubMed
11) 足立雄一, 小児気管支喘息の寛解と治療. 日本小児アレルギー学会誌 21 : 271-280, 2007
Medical*Online
12) Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171 : 315-322, 2005
PubMed
13) Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children : a randomized controlled trial. Am J Respir Crit Care Med 175 : 323-329, 2007
PubMed
14) Ito Y, Adachi Y, Itazawa T, et al. Comparison of exhalation time methods (6sec vs. 10sec) of a hand-held exhaled nitric oxide analyzer. Pediatr Pulmonol 45 : 1005-1008, 2010
 
P.109 掲載の参考文献
1) Taniguchi H, Kanbara K, Hishino K, et al. Chest pain relieved with a bronchodilator or other asthma drugs. Allergol Int 58 (3) : 421-427, 2009
PubMed
2) 谷口浩和 神原健太 今西信悟ほか. ロイコトリエン受容体拮抗薬が胸痛に奏効した気管支喘息の1例. 富山中医誌 32 (1・2) : 8-10, 2009
 
3) Whitney EJ, Row JM, Boswell RN. Chest Pain Variant Asthma. Ann Emerg Med 12 : 572-575, 1983
PubMed
4) Farr RS, Kopetzky MT, Sheldon L, et al. Asthma without Wheezing. Chest 63 (4) (suppl) : 64S-68S, 1973
 
5) 谷口浩和 神原健太 今西信吾ほか. 右胸痛と頭痛を主訴とした胸痛喘息の1例. 日呼吸会誌 46 (3) : 216-219, 2008
 
6) 須甲松伸 伊藤幸治. Chest pain variant asthmaと考えられた1例. アレルギーの領域 1 (11) : 1428-1431, 1994
 
7) 谷口浩和 神原健太 今西信悟ほか. 深吸気時に右胸痛を呈した胸痛喘息の1例, 日胸 67 (9) : 786-789, 2008
 
8) 谷口浩和 神原健太 山端潤也ほか. 胸痛喘息の1例. 富山中医誌 31 (3・4) : 46-48, 2008
 
9) 谷口浩和. 胸骨部の絞扼感と呼吸困難を呈した32歳の女性. 日内会誌 97, 2820-2821, 2844-2845, 2008
 
10) 谷口浩和 神原健太 今西信悟ほか β2刺激薬吸入により喫煙誘発胸痛発作が消失した1例. 日呼吸会誌 46 (7) : 530-534, 2008
Medical*Online
11) 佐野靖之 越野健. Chest Pain Variant Asthma. 別冊 日本臨牀 領域別症候群シリーズ No. 3 呼吸器症候群 (上巻) : 345-348, 1994
 
12) 谷□浩和 市村昇悦. オグザレル塩酸塩が胸骨部絞扼感に奏効した1例, アレルギー 58 (3・4) : 392, 2009
 
13) Edmondstone WM. Chest pain and non-respiratory symptoms in acute asthma. Postgrad Med J 76 : 413-414, 2000
PubMed
14) 谷□浩和 神原健太 今西信悟ほか. Chest pain variant asthmaの1例. アレルギー 57 (1) : 55-58, 2008
 
15) Corrao WM, Braman SS, Irwin RS, et al. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 300 : 633-637, 1979
PubMed
P.114 掲載の参考文献
1) 松瀬厚人 河野茂. アレルギー性気管支肺アスペルギルス症. 呼吸 29 : 640-645, 2010
Medical*Online
2) Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 135 : 805-826, 2009
PubMed
3) Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 86 : 405-414, 1977
PubMed
4) Matsuse H, Tsuchida T, Fukahori S, et al : Dissociation between sensitizing and colonizing fungi in patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma immunol 111 (3) : 190-193, 2013
PubMed
5) van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 62 : 276-277, 2007
PubMed
6) Wark PA, Gibson PG, Wllson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev (3) : CD001108, 2004 (Review)
 
P.117 掲載の参考文献
1) Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321 : 569-574, 1989
PubMed
2) Allen JN, Liao Z, Wewers MD, et al. Detection of IL-5 and lL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. JAllergy Clin Immunol 97 : 1367-1375, 1996
 
3) Uchiyama H, Suda T, Nakamura Y, et al. Alterations in Smoking Habits Are Associated With Acute Eosinophilic Pneumonia. Chest 133 : 1174-1180, 2008
PubMed
4) Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking : a case report including cigarette-smoking challenge test. Intern Med 41 : 1016-1020, 2002
PubMed
5) 伊藤理 谷口博之 近藤康博ほか. 喫煙誘発試験が陽性であった急性好酸球性肺炎の1例. 日呼吸会誌 37 : 424-428, 1999
Medical*Online
6) 山沢英明 大野彰二 中屋孝清ほか. 著明な末梢血好中球増多を呈したミノサイクリンによる急性好酸球性肺炎の1例. 日呼吸会誌 46 : 820-824, 2008
Medical*Online
7) Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center Dust. Am J Respir Crit Care Med 166 : 797-800, 2002
 
8) Miyazaki E, Sugisaki K, Shigenaga T, et al. A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre. Am J Respir Crit Care Med 151 : 541-543, 1995
PubMed
9) Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 60 : 841-847, 2005
PubMed
10) Fujimura M, Yasui M, Shinagawa S, et al. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia : acute, chronic and drug-induced eosinophilic pneumonia. Respiratory Medicine 9 : 2743-2749, 1998
 
11) Miyazaki M, Nureki S, Ono E, et al. Circulating thymus-and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury. Chest 131 (6) : 1726-1734, 2007
 
12) Daimon T, Tajima S, Oshikawa K, et al. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid inpatients with acute eosinophilic pneumonia. Intern Med 44 : 811-881, 2005
 
13) Daimon T, Johkoh T, Sumikawa H, et al. Acute eosinophilic pneumonia : Thin-section CT findings in 29 patients. Eur J Radiol 65 : 462-467, 2008
PubMed
14) 持丸博 川本雅司 福田悠ほか. 急性好酸球性肺炎と慢性好酸球性肺炎の臨床病理学的相違. 日呼吸会誌 45 : 223-232, 2007
 
15) 阿保未来 中村博之 斉藤勝彦ほか. 薬剤リンパ球刺激試験陽性. 薬剤チャレンジテスト陰性の特発性好酸球性肺炎の一例. 気管支学 22 : 98-103, 2000
 
16) 日本呼吸器学会, 編. 薬剤性肺障害の評価. 治療についてのガイドライン, メディカルレビュー社. 大阪 : pp44, 2006
 
P.122 掲載の参考文献
1) Fraser RG, et al. Diagnosis of Diseases of the Chest, 4th ed. WB Saunder. Philadelphia : pp1743, 1999
 
2) Carrington CB, et al. Chronic eosinophilic pneumonla. N Engl J Med 280 : 787-798, 1969
 
3) Gaensler EA, et al. Peripheral opacities in chronic eosinophilic pneumonia, the Photographic negative of pulmonary edema. Am J Roentgenol 128 : 1-13, 1977
 
4) 北川正信. 器質化肺炎-好酸球性肺炎の新しい見方とBOOP批判-. 呼吸と循環 37 : 387-394, 1989
 
5) 望月吉郎ほか. 慢性好酸球性肺炎の予後の検討. 日呼吸会誌 40 : 851-855, 2002
Medical*Online
P.128 掲載の参考文献
1) G6mez-Puerta JA, et al. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis : an update. Am J Pathol 175 : 1790-1798, 2009
 
2) Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritls Rheum 37 : 187-192, 1994
PubMed
3) Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody : possible arbovirus aetiology? Br Med J (Clin Res Ed) 285 : 606, 1982
PubMed
4) 藤元昭一. RPGN, ANCA関連血管炎の疫学. 日腎会誌 51 : 84-87, 2009
 
5) Bosch X, et al. Antineutrophil cytoplasmic antibodies. Lancet 368 : 404-418, 2006
PubMed
6) 熊谷俊一. 阪神大震災に発生したMPA. Frontiers in Rheumatology & Clinical Immunology 3 : 48-49, 2009
 
7) Holie JU, Gross WL. ANCA-associated vasculitides : pathogenetic aspects and current evidence-based therapy. J Autoimmu 32 : 163-171, 2009
 
8) 滝澤始. ANCA, 内科 93 : 2004
 
9) 村松崇 猪熊茂子. 当科で経験した顕微鏡的多発血管炎におけるMPO-ANCA抗体価と障害臓器についての検討. 第20回日本アレルギー学会春季臨床大会抄録集 : 2008
 
10) 小林祥子 猪熊茂子. Intrapulmonary Hemorrhage in Collagen-Vascular Diseases Includes a Spectrum of Underlying Conditions. Inter Med 48 : 891-897, 2009
 
11) Cortese G. Radiological aspects of diffuse alveolar haemorrhage, Radlol Med 113 : 16-28, 2008
PubMed
12) Levy JB. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66 : 1535-1540, 2004
PubMed
13) Yang G. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol 63 : 423-428, 2005
PubMed
14) Watts R. Development and validation of a consensus methodology for the ciassification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66 : 222-227, 2007
 
15) Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33 : 1094-1100, 1990
PubMed
16) Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis, Arthritis Rheum 33 : 1101-1107, 1990
PubMed
17) Fauci AS, Wegener's granulomatosis : prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98 : 76-85, 1983
PubMed
18) Jayne D. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic auto-antibodies. N Engl J Med 349 : 36-44, 2003
 
19) Bosch X, et al, Treatment of antineutrophil cytoplasmic antibody associated vasculitis : a systematic review. JAMA 298 : 655-669, 2007
PubMed
20) Weixin Hu, et al. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant 23 : 1307-1312, 2008
PubMed
21) Robert AF, et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18 : 2189-2197, 2007
 
22) Stone JH, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med. 15 ; 363 (3) : 221-32, 2010
 
23) 尾崎承一. RiCRAV報告厚生労働省ANCA関連血管炎のわが国における治療法の確立のための多施設共前向き臨床研究第21年度総括・分担研究報告書. 99-102, 2010
 
24) Ozaki S, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis : the JMAAV study. Mod Rheumatol, 22 (3) ; 394-404, 2012
PubMed
P.132 掲載の参考文献
1) Wiedemann HP, Matthay RA, et al. Pulmonary manifestation of systemic lupus erythematosus. J Thoracic Imaging 7 : 1-18, 1992
PubMed
2) 膠原病診療ノート第2版 : pp79
 
3) 大曾根康夫. 免疫と疾患 3 : 785, 1982
 
4) Matthay B, et al. Pulmonary manifestation of systemic lupus erythematosus : Review of twelve cases of acute lupus pneumonitis. Medicine 54 : 397-409, 1974
 
5) 梶山通. 急性ループス肺炎で死tした全身性エリテマトーデスの一例. 小児科臨床 44 (5) : 1183-1186, 1991
 
6) Khor CG, et al. Pulmonary manifestation as initial presentation for systemic lupus erythematosus. International Journal of Rheumatic Diseases : 2014
PubMed
7) 石垣武男. 全身性エリテマトーデスの胸部X線像. 呼吸 7 (9) : 1033-1037, 1988
 
8) 胸部のCT 第3版. メディカルサイエンスインターナショナル : pp470
 
9) 肺HRCT 原書4版. 丸善出版 : pp270-271
 
10) 定形綾香. 間質性肺炎を伴うRAの経過中. SLE発症と同時に肺病変の急性増悪を来した一例. 日呼吸会誌 40 (9) : 756-761, 2002
 
11) Primack SL, et al. Radiologic manifestations of the Systemic autoimmune diseases. Clin Chest Med 19 : 573-586, vii ; 1998
 
12) Cunha BA, et al. SLE pneumonitis mimicking swine influenza pneumonia during the swine influenza (H1N1) pandemic. Heart & Lung 40 : 462-466, 2011
PubMed
13) 土肥眞. SLEに伴う肺病変. 呼吸 29 (7) : 730-735, 2010
Medical*Online
14) Wiedemann HP, Matthay RA, et al. Pulmonary manifestation of the collagen vascular diseases, Clin Chest Med 10 (4) : 677-722, 1989
PubMed
15) Erickson RW, Franklin WA, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthfitis Rheum 24 : 114-123, 1994
PubMed
P.137 掲載の参考文献
1) Connors GR, Chrstopher-Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies : what progress has been made in the past 35 years? Chest 138 : 1464-1474, 2010
 
2) Kondoh Y, Taniguchi H, Kataoka K, et al. Prognositic factors in rapidly progressive interstitiai pneumonia, Respirology 15 : 257-264, 2010
 
3) Schwarz MI. The lung in polymyositis. Clin Chest Med 19 : 701-712, 1998
 
4) Kotani T, Takeuchi T, Makino S, et al, Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acutelsubacute interstitial pneumonia. Clin Rheumatol 30 : 1021-1028, 2011
PubMed
5) Suda T, Fujisawa T, Enomoto N, et al. Interstitial lung diseases associated with amyopathic dermatomyositis, Eur Respir J 28 : 1005-1012, 2006
PubMed
6) Sato S, Hirakata M, Kuwana M, et al, Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritls Rheum 52 : 1571-1576, 2005
PubMed
7) Gono T, Kawaguchi Y, Ozeki E, et al. Serum ferritin correlates with activity of anti-MDAs antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 21 : 223-227, 2011
 
8) 高橋弘樹 干葉弘文 林伸好ほか, 間質性肺炎における抗SP-D自己抗体, 厚生労働科学研究平成20年度報告書 : p75-80, 2009
 
9) Tanizawa K, Handa T, Nakashima R, et al. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105 : 1380-1387, 2011
PubMed
10) Lakhanpal S, Lie JT, Conn DL, et al. Pulmonary disease in polymyositis/dermatomyositis : a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 46 : 23-29, 1987
PubMed
11) Takada K, Nagasaka K, Miyasaka N. Polymyositis/dermatomyositis and interstitial lung disease : a new therapeutic approach with T-cell-specific immunosuppressants, Autoimmunity 38 : 383-392, 2005
 
12) Yamasaki Y, Yamada H, Yamasaki M, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology 46 : 124-130, 2007
PubMed
13) Suzuki Y, Hayakawa, Miwa S, et al. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis, Lung 187 : 201-206, 2009
PubMed
14) Nagai K, Takeuchi T, Kotani T, et al. Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis, Mod Rheumatol 21 : 32-36, 2011
PubMed
15) Koreeda Y, Higashimoto I, Yamamoto M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 49 : 361-369, 2010
PubMed
16) Mukae H, Ishimoto H, Sakamoto N, et al, Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136 : 1341-1347, 2009
PubMed
P.142 掲載の参考文献
1) Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposlum on the definition and management of anaphylaxis : summary report. J Allergy Clin Immunol 117 : 391-397, 2006
PubMed
2) Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis : findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97 596-602, 2006
 
3) Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 101 : 139-143, 2008
 
4) Simonds FER, Ardusso LRF, Bilo MB, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Imuunol 127 : 593. e1-22, 2011
 
5) Simons FER. Anaphylaxis. J Allergy Clin Immunol 121 : S402-407, 2008
PubMed
6) Lieberman P, Kemp SF, Oppenheimer J, et al. The diagnosis and management of anaphylaxis : an updated practice parameter. J Allergy Clin Immunol 115 : S483-523, 2005
 
7) Simons FER, Sheikh A. Anaphylaxis : the acute episode and beyond. BMJ 346 : f602, 2013
PubMed
8) 海老澤元宏 西間三馨 秋山一男ほか. アナフィラキシー対策とエピペン(R) アレルギー 62 : 144-154, 2013
Medical*Online
9) Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anapfylaxis. J Dermatol Sci 47 : 109-117, 2007
PubMed
P.148 掲載の参考文献
1) 谷口正実 東憲孝 小野恵美子ほか. NSAIDs不耐症の病態, 診断. 治療呼吸 31 (3) : 209-218, 2012
 
2) 谷口正実. アスピリン喘息 (NSAIDs過敏喘息). 日内会誌 102 (6) : 1426-1432, 2013
 
3) Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118 (4) : 773-786, 2006
PubMed
4) Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16 (3) : 432-436, 2000
PubMed
5) Szczeklik A, Sanak M. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors. Clin Exp Allergy 32 (3) : 339-342, 2002
PubMed
6) Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, Osame M, Akiyama K. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria) : Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis, J Allergy Clin Immunol 113 (2) : 277-283, 2004
PubMed
7) Fukutomi Y, et al. Obesity and aspirin intolerance are risk factors for difficult-to-treat asthma in Japanese non-atopic women. Clin Exp Allergy 42 (5) : 738-746, 2012
PubMed
8) Higashi N, Mita H, Ono E, Fukutomi Y, Yamaguchi H, Kajiwara K, Tanimoto H, Sekiya K, Akiyama K, Taniguchi M. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. J Allergy Clin Immunol 125 (5) : 1084-1091, 2010
PubMed
9) 谷口正実 三井千尋 東憲孝ほか. アスピリン喘息の病態, 機序-最近の知見から. アレルギー・免疫 20 (7) : 1000-1010, 2013
 
10) Yamaguchi H, Higashi N, Mita H, Ono E, Komase Y, Nakagawa T, Miyazawa T, Akiyama K, Taniguchi M. Urinary concentrations of 15-epimer of lipoxin A (4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 41 (12) : 1711-1718, 2011
PubMed
11) Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 115 (6) : 1189-1196, 2005
PubMed
12) 谷口正実ほか. 鼻茸・アスピリン喘息, 喘息 25 (1) : 45-53, 2012
Medical*Online
13) Okano M, Fujiwara T, Haruna T, Kariya S, Makihara S, Higaki T, Nishizaki K. Prostaglandin E (2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasai polyps. J Allergy Clin Immunol 123 (4) : 868-874, 2009
 
14) 谷口正実 東憲孝 東愛 谷本英則 福冨友馬 関谷潔史 押方智也子 小野恵美子 粒来崇博 釣木澤尚実 大友守 前田裕二 森晶夫 長谷川眞紀 秋山一男, 呼吸器診療におけるリスクマネージメント アスピリン喘息のプライマリケア-特にそのリスクマネージメントについて-. 呼吸 25 (8) : 791-797, 2006
 
15) 谷口正実. 気道過敏性検査とアスピリン負荷試験の実際. アレルギー 58 (2) : 87-96, 2009
Medical*Online
16) Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of crosssensitivity with acetaminophen in aspirin-sensitive asthmatic subjects, J Allergy Clin Immunol 96 (4) : 480-485, 1995
PubMed
17) 谷口正実. アスピリン喘息における点滴静注ステロイド薬の使い方. アレルギーの臨床 23 (9) : 87-89, 2003
 
18) 妹川史朗ほか : クロモグリク酸ナトリウムは発作寛解期のアスピリン喘息患者に対して急性気管支拡張効果を有する. アレルギー 41 (10) : 1515-1520, 1992
Medical*Online
19) 谷口正実. NSAIDs不耐症におけるアスピリン減感作の意義と施行法, アレルギー 57 (6) : 673-684, 2008
 

IV. 外的要因

P.153 掲載の参考文献
1) 市丸智浩 樋口収 足立雄一ほか, 宿題報告 : 小児における気管・気管支異物の全国調査結果-予防策の推進に向けて-. 日本小児呼吸器疾患学会誌 19 : 85-89, 2008
 
2) Higuchi O, Adachi Y, Ichimaru T, et al. A nationwide survey of tracheobronchial foreign body aspiration cases in Japan. Int J Pediatr Otorhinolaryngol 75 : 659-661, 2009
 
3) 本間仁 榊久乃 板澤寿子 中林玄一ほか. なぜ気道異物が診断されるまでに長期間を要したのか-ピーナッツ吸引の3小児例の検討-. 日本小児呼吸器疾患学会誌 16 : 21-26, 2005
 
4) 樋口収 足立雄一. ニューロペプタイド研究会, 編. 気道異物「こどもの咳嗽 診断ガイドブック」, 診断と治療社, 東京 : pp83-85, 2011
 
5) 宮坂勝之, 翻訳, 編. PALSスタディガイド, エルゼビア・ジャパン. 東京 : 2008
 
6) Cohen S, Avital A, Godfrey S, et al. Suspected foreign body inhalation in children : what are the indications for bronchoscopy? J Pediatr 155 : 276-280, 2009
PubMed
7) Higuchi O, Adachl Y, Adachi YS, et al. Mothers' knowledge aboutforelgn body aspiration in young children. Int J Pediatr Otorhinolaryngol. 77 : 41-44, 2013
 
8) http://jspp1969.umin.jp/ind_img/cc03.pdf
 
P.156 掲載の参考文献
1) 日本熱傷学会. 熱傷診療ガイドライン, 17-18, 2009
 
2) 田熊清継. BURN熱傷の初期診療と局所抗菌薬・化学療法の指標. 35-39, 2008
 
3) 相川直樹. 気道熱傷. 治療 64 107-111, 1982
 
4) Bingham HG, Gallagher TJ, Powell MD. Early bronchoscopy as a predictor of ventilatory support for burned patients. J Trauma 27 : 1286, 1987
PubMed
5) Weiss SM, Lakshminarayan S. Acute inhalation injury. Clin Chest Med 15 : 103, 1994
PubMed
6) Clark WR Jr. Smoke inhalation : diagnosis and treatment. World J Surg 16 : 24, 1992
PubMed
7) Heimbach DM, Waeckerle JF, Inhalation injunes. Ann Emerg Med 17 : 1316, 1988
PubMed
8) The ARDS Definition Task Force : Acute respiratory distress syndrome. JAMA 307 : 2526-2533, 2012
PubMed
9) Valova M, Konigova R, Broz L, et al. Early and late fatal complications of inhalation injury. Acta Chir Plast 44 (2) : 51-54, 2002
PubMed
10) Kao CC, Garner WL. Acute burns. Plast Reconstr Surg 105 : 2482, 2000
 
11) Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347 (14) : 1057-1167, 2002
PubMed
P.159 掲載の参考文献
1) Rose CS, Blanc PD. Inhalation fever. In : Rom WN, ed. Environmental and Occupational Medicine. 3rd ed, Lippincott-Raven. Philadelphia : pp467-480, 1998
 
2) 日下幸則. 金属肺. 日本臨牀別冊 領域別症候群 3 呼吸器症候群 (上巻) 52 : 531-534, 1994
 
3) Gordon T, Fine JM. Metal fume fever. Ocoup Med 8 : 504-517, 1993
PubMed
4) Vogelmeier C, Konig G, Bencze K, et al. Pulmonary involvement in zinc fume fever. Chest 92 : 946-948, 1987
PubMed
5) Blount BW. Two types of metal fume fever : mild vs. serious. Mil Med 155 : 372-377, 1990
PubMed
6) Buttersby R. 溶融亜鉛めっき-その健康への影響. 鉛と亜鉛 21 : 21-26, 2001
 
7) Kuschner WG, D'Alessandro A, Wintermeyer SF, et al. Pulmonary responses to purified zinc oxide fume. J Investig Med 43 : 371-378, 1995
 
8) Fine JM, Gordon T, Chen LC, et al. Metal fume fever : characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxlde fume at and below the threshold limit value. J Occup Environ Med 39 : 722-726, 1997
PubMed
9) Blanc PD, Boushey HA, Wong H, et al. Cytokines in metal fume fever. Am Rev Respir Dis 147 : 134-138, 1993
PubMed
10) Jeng HA, Sanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox HaZard Subst Environ Eng 41 : 2699-2711, 2006
 
11) El-Zeon M, Malo JL, Infante-Rivard C, et al. Prevalence and association of welding related systemic and respiratory symptoms in welders. Occup Environ Med 60 : 655-661, 2003
 
12) El-Zein M, Infante-Rivard C, Malo JL, et al. Is metal fume fever a determinant of welding related respiratory symptoms and/or increased bronchial responslveness? A longitudinal study, Occup Environ Med 62 : 688-694, 2005
PubMed
13) Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles : can in vitro assays accurately forecast lung hazards foliowing inhalation exposures? En viron Sci Technol 43 : 7939-7945, 2009
 
14) 外山勝弘 木村一博 宮下美奈穂ほか. テフロン(R) 加工フライパン4時間の過燃焼により生じたフューム吸入による肺水腫の1例. 日呼吸会誌 44 : 727-731, 2006
Medical*Online
15) 日本産業衛生学会, 産業保健 II 第一版, 篠原出版 : pp287-323, 1985
 
P.163 掲載の参考文献
1) Reed CE, Sosman A, Barbee RA. Pigeon-breeder's lung. A newly observed interstitial pulmonary disease, JAMA 193 : 261-265, 1965
 
2) Fink JN, Sosman AJ, Barboriak JJ, et al, Pigeon breeder's disease. A clinical study of a hypersensitivity pneumonitis, Ann Intern Med 68 : 1205-1219, 1968
 
3) Kuramochi J, Inase N, Takayama K, et al. Detection of indoor and outdoor avian antigen in management of birdrelated hypersensitivity pneumonitis. Allergol Int 59 : 223-228, 2010
PubMed
4) Ohtani Y, Saiki S, Sumi Y, et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 90 : 604-610, 2003
PubMed
5) Lacasse Y, Selman M, Costabel U, et al. Classification of hypersensitivity pneumonitis. A hypothesis. Int Arch Allergy Immunol 149 : 161-1666, 2009
PubMed
6) Edwards C, Luntz G. Budgerigar-fancier's lung : a report of a fatal case. Brit J Dis Chest 68 : 57-64, 1974
PubMed
7) Ohtani Y, Inase N, Miyake S, et al. Fatal outcome in chronic bird fancier's lung. Am J Med 112 : 588-590, 2002
PubMed
8) Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung : histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 60 : 665-671, 2005
PubMed
9) Tateishi T, Ohtani Y, Takemura T, et al. Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. J Comput Assist Tomogr 35 : 272-279, 2011
PubMed
10) Silva CIS, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis : Differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 246 : 288-297, 2008
PubMed
11) Takemura T, Akashi T, Ohtani Y, et al, Pathology of hypersensitivity pneumonitis. Curr Opinion Pulm Med 14 : 440-454, 2008
 
12) Yoshizawa Y, Miyake S, Sumi Y, et al. A follow-up study of pulmonaryfunction tests, bronchoalveolar lavage cells, and humoral and cellular immunity in bird fancier's lung. J Allergy Clin Immunol 96 : 122-129, 1995
 
13) Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest 118 : 1382-1389, 2000
PubMed
14) Miyazaki Y, Tateishi T, Akashi T, et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 134 : 1265-1270, 2008
PubMed
15) Kuramochi J, Inase N, Miyazaki Y, et al. Lung cancer in chronic hypersensitivity pneumonitis. Respiration 82 : 263-267, 2011
PubMed
P.168 掲載の参考文献
1) 内山巌雄. シンポジウム 1 化学物質過敏症, 化学物質過敏症の実態調査. アレルギー 51 : 805-808, 2002
 
2) Cullen MR. Multiple chemical sensitivities : summary and directions for future investigators. Occup Med 2 : 801, 1987
PubMed
3) 長谷川眞紀 大友守 三田晴久ほか. 化学物質過敏症可能性例の検討 : アレルギーの観点から. アレルギー 54 : 478-484, 2005
Medical*Online
4) 坂部貢. 特集 シックハウス症候群 シックハウス症候群と化学物質過敏症～オーバービュー～. アレルギー・免疫 10 : 15-19, 2003
 
5) Hillert L, Musabaslc V, Berglund H, et al. Odor processing in multiple chemical sensitivity. Hum Brain Mapp 28 : 172-182, 2007
 
6) 水城まさみ. 唾液中クロモグラニンA測定を用いた, カプサイシンおよびトルエン負荷によるストレス反応パターンの検討～化学物質過敏症と健常者を対象に～. 職業・環境アレルギー 16 : 37-47, 2009
 
7) 及川佐枝子 加藤琢磨 栗林景容ほか, トリプチルスズのTh2優位性を介したアレルギー性疾患増悪作用, 日本衛生学雑誌 64 : 372, 2009
 
8) 松坂恭成 青山美子 角田和彦ほか. シックハウス症候群におけるNeuropathy Target Esterase (NTE) 酵素活性と遺伝子多型. 臨床環境医学 16 : 98-103, 2007
 
9) 石川哲 宮田幹夫. 化学物質過敏症-診断基準・診断に必要な検査法. アレルギー免疫 6 : 990-998, 1999
 
10) Editorial. Multiple chemical sensitivity : A 1999 Consensus. Arch En viron Health 54 : 14-149, 1999
 
11) 厚生労働科学研究費補助金 健康安全・危機管理対策総合研究事業シックハウス症候群の診断基準の検証に関する研究 平成21年度研究報告書 研究代表者 相澤好治 : 2010
 
12) 水城まさみ 山田博之. シックハウス症候群の病型分類についての一考察～長期観察できた症例を中心に～, アレルギー 59 : 1423, 2010
Medical*Online
13) Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity lnventory (EESI) : a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicollnd Ind Health 15 : 370-385, 1999
PubMed
14) Hojo S, Kumano H, Yoshino H, et al. Application of Quick Environment Exposure Sensitivity Inventory (QEESI) for Japanese population : study of reliability and validity of the questionnaire. Toxicol Ind Health 19 : 41-49, 2003
 
15) 水城まさみ. シックハウス症候群の診断-問診票の有用性. 臨床免疫・アレルギー科 46 : 175-181, 2006
 
16) Nogami H, Odajima H, Shoji S, et al. Capsaicin provocation test as a diagnostic method for determining multiple chemical sensitivity. Allergology International 53 : 153-157, 2004
 
17) 長谷川眞紀 大友守 秋山一男. シックハウス症候群・化学物質過敏症患者の静脈血酸素分圧の検討. アレルギー 54 : 1138, 2005
 
18) 水城まさみ 山田博之. 乳幼児期からの頻回の農薬曝露が誘因と考えられたPVO2が指標となった化学物質過敏症の1例. アレルギー 58 : 1301, 2009
 
19) 水城まさみ 山田博之. 気道過敏性亢進を有する化学物質過敏症患者に対するステロイド吸入療法の有用性, アレルギー 57 : 452, 2008
Medical*Online
P.173 掲載の参考文献
1) Beers MF. Therapy and Pulmonary Oxygen Toxicity. In : Fishman's pulmonary diseases and disorders, 4th ed (ed by Fishman AP, et al). McGraw-Hill, New York : pp2613-2630, 2008
 
2) 吉矢生人 天野勝. 酸素中毒. 新生理科学大系 第17巻, 星猛, 伊藤正男, 編. 医学書院. 東京 : pp391-398, 2000
 
3) 日本呼吸器学会肺生理専門委員会 日本呼吸管理学会酸素療法ガイドライン作成委員会. 酸素療法ガイドライン. メディカルビュー 東京 : 2006
 
4) O'Driscoll BR, Howard LS, Davison AG : BTS guideline for emergency oxygen use in adult patients. Thorax 63, Suppl 6 : ppvi 1-68, 2008
 
5) Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit : why more is not always better. Curr Opin Crit Care 13 : 73-78, 2007
 
6) Farquhar H, Weatherall M, Wijesinghe M, et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 158 : 371-377, 2009
PubMed
7) 丸山一男 張尓泉. 酸素 : でも, 酸素は薬? 毒? 高濃度酸素投与の生理的影響. Life Support and Anesthesia 15 : 332-337, 2008
 
8) 鈴木幸男. ARDSのすべて 第4章 ARDSの基礎疾患 高濃度酸素による肺損傷. 医学のあゆみ 増刊 : 198-202, 2004
 
9) Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Rharmacol Toxicol 53 : 401-426, 2013
PubMed
10) Sinclair SE, Altemeier WA, Matute-Bello G, et al. Augmented lung injury due to interaction between hyperoxia and mechanical ventilation. Crit Cere Med 32 : 2496-2501, 2004
 
11) 夜久英明 森川修 佐藤仁昭ほか. 臓器不全の治療-どのように行っているか 呼吸不全. 外科治療 92 : 982-992, 2005
Medical*Online
12) 照屋孝二 須加原一博. 酸素 : でも, 酸素は薬? 毒? 間質性肺炎と酸素投与. LiSA 15 : 350-355, 2008
 
13) Downs JB. Has oxygen administration delayed appropriate respiratory care? Fallacies regarding oxygen therapy. Respir Care 48 : 611-620, 2003
PubMed
14) 金碧年 西脇公俊 島田康弘, III 呼吸. 循環系の術技 外科救急処置アトラス 12, 酸素投与法. 外科治療 94 : 510-515, 2006
 
15) Tan A, Schulze A, O'Donnell CP, et al. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev. CD002273, 2005
PubMed

V. 外傷

P.179 掲載の参考文献
1) 日本外傷学会臓器損傷分類 2008 : 日本外傷学会, 外傷用語集 (改訂版 2008), 春恒社 : pp53, 2008
 
2) Devitt JH, Boulanger BR. Lower airway injuries and anaesthesia, Can J Anaesth 43 : 148-159, 1996
PubMed
3) Lee RB. Traumatic injury of the cervicothoracic trachea and major bronchi. Chest Surg Clin Nor Am 7 : 285-304, 1997
 
4) Kirsh MM, Orringer MB, Behrendt DM, et al. Manegement of tracheaobronchial disruption secondary to nonpenetrating trauma. Ann Thorac Surg 22 : 93-101, 1976
 
5) Calhoon JH, Grover FL, Trinkle JK, Chest trauma. Thoracic Surgical Consideration for the Pulmonologist 13 : 55-67, 1992
 
6) Levin B. The continuous diaphragm sign. Clin Radiol 24 : 337-338, 1973
PubMed
7) Naclerio EA, The "V sign" in the diagnosisof spontaneous rupture of esophagus, Am J Surg 93 : 291-298, 1957
 
8) 西海昇 藤森賢 濱本篤ほか. 胸部単純X線写真が診断に有効であった右主気管支断裂損傷の1例. 日呼外会誌 16 (1) : 85-89, 2002
 
9) Iwasaki M, Kaga K, Inoue H, et al. Bronchoscopy findings and early treatment of patients with blunt tracheo-bronchial trauma, J Cardiovasc Surg 35 : 269-271, 1994
PubMed
10) Ichinose J, Kohno T, Fujimori S. Video-assisited thoracic sugery for pulmonary aspergilloma. Interact Cardiovasc Thorac Surg 10 (6) : 927-930, 2010
 
11) Miyazu Y, Miyazawa T, Kurimoto N, et al. Endobronchial ultrasonography in the diagnosis and treatment of relapsing polychondritis with tracheobronchial malacia. Chest 24 : 2393-2395, 2003
 
12) 宮澤輝臣. 硬性気管支鏡・ステント. 気管支学 32 : 446-452, 2010
Medical*Online
P.184 掲載の参考文献
1) Macklin CC. Transport of air along sheaths of pulmonic blood vessels from alveoli to mediastinum. Arch Intern Med 64 : 913-926, 1939
 
2) Cyrink D, Milne ENC, Imray EJ. Pneumomediastinum, a diagnostic problem. Crit Rev Diagn Imaging 23 : 75-117, 1984
 
3) 阪本仁 小坂真二 土屋恭子. 特発性縦隔気腫の臨床的検討. 日呼外会誌 23 : 918-922, 2008
 
4) Vivek NI, Avni YJ, Jay HR. Spontaneous pneumomediastinum : Analysis of 62 consecutive adult patients. Mayo Clin Proc 84 : 417-421, 2009
 
5) Fujiwara T. Pneumomediastinum in pulmonary fibrosis : Detection by computed tomography. Chest 104 : 44-46, 1993
PubMed
6) Hasegawa M, Hashimoto K, Morozumi M, Ubukata K, et al. Spontaneous pneumomediastinum complicating pneumonia in chiidren infected with the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect 16 : 195-199, 2010
 
7) Kiser AC, O'Brien SM, Detterbeck FC. Blunt tracheobronchial injury : Treatment and outcomes. Ann Thorac Surg 71 : 2059-2065. 2001
PubMed
8) Derbes VJ, Mitchell RE Jr. Hermann Boerhaave's Atrocis, nec descripti prius, morbi historia, the first translation of the classic case report of rupture of the esophagus, with annotation. Bull Med Libr Assoc 24 : 97-98, 1955
 
9) 曽和晃正 山田徹 渡辺昌樹 千葉渉 篠置哲ほか. 特発性食道破裂 (Boerhaave症候群). 胸部外科 61 : 572-575, 2008
 
10) 千野修 幕内博康 田仲曜 島田英雄ほか, 特発性食道破裂の治療方針と胸腔ドレナージに関する臨床的検討. 日本腹部救急医学会雑誌 24 : 717-725, 2004
 
11) Fikkers BG, Veen JA, Kooloos JG, Pickkers P, et al. Emphysema and pneumothorax after percutaneous tracheostomy : case report and an anatomic study. Chest 125 : 1805-1814, 2004
 
12) Solh AA, Jaafar W. A comparative study of the complications of surgicaltracheostomy in morbidly obese critically ill patients. Crit Care 11 : R3, 2007
PubMed
13) Quigley JP, Brady DA. A physiologic and clinical study of the pressure development in the digestive tract. Am J Med 47 : 73-81, 1952
 
14) Ho HC, Burchell S, Morris P, Yu M. Colon perforation, bilateral pneumothoraces, pneumopericardium, pneumomediastinum, and subcutaneous emphysema complicating endoscopic polypectomy : Anatomic and management considerations, Am Surg 62 : 770-774, 1996
PubMed
15) Soto AC, Salinas AC, Aledo VS, Barrio AB, et al. Spontaneous pneumomediastinum : Descriptive study of our experience with 36 cases. Arch Bronchopneumol 41 : 528-531, 2005
 
16) Bejvan S, Godwin D. Pneumomediastinum : Old signs and new signs. AJR 166 : 1041-1048, 1996
 
17) Sinha R. Naclerio's V sign, Radiology 245 : 296-297, 2007
 
18) Dissanaike S, Shalhub S, Jurkovich GJ. The evaluation of pneumomediastinum in blunt trauma patients. J Trauma 65 : 1340-1345, 2008
PubMed

VI. 先天性

P.190 掲載の参考文献
1) Roos DB, The place for scalenectomy and first-rib resection in thoracic outlet syndrome. Surg 92 : 1077-1085, 1982
 
2) Hurlbert SN, Rutherford RV, Subclavian-axillary vein thrombosis. In : Rutherford RB, ed. Vasvular Surgery, 5th ed, WB Saunders Co. Philadelphia : pp1087-1093, 2000
 
3) Makhoul RG, Machleder HI, Developmental anomalies at the thoracic outlet : An analysis of 200 consecutive cases. J Vasc Surg 16 : 534-545, 1992
 
4) Sanders RJ, Cooper MA, Hammond SL, Weinstein ES. Neurogenic thoracic outlet syndrome. In : Rutherford RB, ed, Vascular Surgery. 5th ed. WB Saunders Co. Philadelphia : pp 1184-2000, 2000
 
5) Gergoudis R, Barnes RW. Thoracic outlet arterial compression : Prevalence in normal persons. Angiology 31 : 538-541, 1980
PubMed
6) Aligne C, Barral X. Rehabilitation of patients with thoracic outlet syndrome. Ann Vasc Surg 6 : 381-389, 1992
PubMed
7) Reilly LM, Stoney RJ. Supraclavicular approach for thoracic outlet decompression. J Vasc Surg 8 : 329-334, 1988
PubMed
8) Cheng WKS, Stoney RJ. Supraclavicular reoperation for neurogenic thoracic outlet syndrome. J Vasc Surg 19 : 565-572, 1994
 
9) Schneider DB, Dimuzio PJ, Martin ND, et al. Combination treatment of venous thoracic outlet syndrome : Open surgical decompression and intraoperative angioplasty. J Vasc Surg 40 : 599-603, 2004
PubMed
10) Thompson RW, Bartoli MA. Neurogenic thoracic outlet syndrome, In : Rutherford RB, ed. Vascular Surgery, 6th ed, WB Saunders Co. Philadelphia : pp1347-1370, 2006
 
11) Cordobes-Gual J, Lozano-Vilardell P, Torreguitart-Mirada N. et al. Postoperative study of thefunctionalrecovery after surgery for thoracic outlet syndrome. Eur J Vasc Endovasc Surg 35 : 79-83, 2008
PubMed
P.195 掲載の参考文献
1) Tibboel D, Gaag AV. Etiologic and genetic factors in congenital diaphragmatic hernia, Clin Perinatol 23 : 689-699, 1996
PubMed
2) Kantarci S, Casavant D, Prada C, et al. Findings from aCGH in patients with congenital diaphragmatic hernia (CDH) : a possible locus for Fryns syndrome, Am J Med Genet A 140 : 17-23, 2006
PubMed
3) Usui N, Kitano Y, Okuyama H, et al. Reliability of the lung to thorax transverse area ratio as apredictive parameter in fetuses with congenital diaphragmatic hernia. Pediatr Surg Int 27 : 39-45, 2011
 
4) Okazaki T, Nakazawa N, Ogasawara Y, et al. Increase in fetal pulmonary artery diameters during late gestation is a predictor of outcome in congenital diaphragmatic hernia. J Pediatr Surg (in press)
 
5) Kitano Y, Nakagawa S, Kuroda T, et al. Liver position in fetal congenital diaphragmatic hernia retains a prognostic value in the era of lung-protective strategy. J Pediatr Surg 40 : 1827-1832, 2005
PubMed
6) The congenital diaphragmatic hernia study group. Late-presenting congenital diaphragmatic hernia. J Pediatr Surg 40 : 1839-1843, 2005
 
7) Paralta CFA, Sbragia L, Bennini JR, et al. Fetoscopic endotracheal occlusion for severe isolated diaphragmatic hernia : initial experience from a single clinic in Brazil. Feral Diagn Ther 29 : 71-77, 2011
 
8) Harrison MR, Keller RL, Hawgood SB, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 349 : 1916-1924, 2003
PubMed
9) Masumoto K, Teshiba R, Esumi G, et al. Improvement in the outcome of patients with antenatally diagnosed congenital diaphragmatic hernia using gentle ventilation and circulatory stabilization. Pediatr Surg Int 25 : 487-492, 2009
PubMed
10) Okazaki T, Kohno S, Hasegawa S, et al. Congenital diaphragmatic hernia : efficacy of ultrasound examination in its management. Pediatr Surg Int 19 : 176-179, 2003
 
11) Okazaki T, Nishimura K, Takahashi T, et al. Indications for thoracoscopic repair of congenital diaphragmatic hernia in neonates. Pediatr Surg Int 27 : 35-38, 2011
PubMed

VII. 解剖構造の変化 ( 種々の原因による )

P.200 掲載の参考文献
1) 橋爪一光. 気管・気管支軟化症 : 北村論 工藤翔二 石井芳樹, 編. 別冊・医学のあゆみ 呼吸器疾患-state of arts Ver. 5, 医歯薬出版. 東京 : pp478-481, 2007
 
2) 塙健. 気管・気管支軟化症 : 中川勝文, 編. 別冊日本臨床 新領域症候群シリーズ 呼吸器症候群 III, 日本臨牀社. 大阪 : pp722-724, 2009
 
3) Carden KA, Boiselle PM, Waltz DA, et al. Tracheomalacia and tracheobronchomalacia in children and adults. Chest 127 : 984-1005, 2005
PubMed
4) 船津武志 小鯖覚 八木一之ほか. 気管気管支軟化症. 気管支学 4 : 123-135, 1982
 
5) Masaoka A, Yamakawa Y, Niwa H, et al, Pediatric and adult tracheobronchomalacia. Eur J Cardiothorac Surg 10 : 87-92, 1996
PubMed
6) 高尾仁二. 再発性多発性軟骨炎 : 北村論 工藤翔二 石井芳樹, 編. 別冊・医学のあゆみ 呼吸器疾患-state of arts Ver. 5, 医歯薬出版, 東京 : pp485-487, 2007
 
7) McAdam LP, O'Hanlan MA, Bluestone MB, et al. Relapsing polychondritis : prospective study of 23 patients and a review of the literature. Medicine 55 (3) : 193-215, 1976
 
8) 中川英之 山本勝丸. 抗type II collagen抗体が陽性であった気管・気管支軟化症の1例. 気管支学 29 (3) : 195-198, 2007
Medical*Online
9) 中野淳 岡本卓 亀山耕太郎ほか. 気管切開後に刀鞘型気管軟化症を認めた再発性多発軟骨炎の1例. 気管支学 26 (7) : 629-632, 2004
Medical*Online
10) Segel MJ, Godfrey S, Berkman N, Relapsing polychondritis : reversible airway obstruction is not aiways asthma. Mayo Clin Proc 79 : 407-409, 2004
PubMed
11) 正岡昭 水野武郎 市村秀樹ほか. Crescent type気管・気管支軟化症に対する形成症例-膜様部縫縮による形成-. 気管支学 5 : 255-262, 1983
 
12) 行武正伸 岡本直樹 粟屋幸一ほか. ステント再挿入によって人工呼吸器から離脱し得た気管気管支軟化症の1例. 日内会誌 94 (12) : 2603-2605, 2005
 
13) Ferguson GT, Benoist J. Nasal continuous positive airway pressure in the treatment of tracheobronchomalacia. Am Rev Respir Dis 147 : 457-461, 1993
PubMed
14) Nuutinen J. Acquired tracheobronchomalacia. Eur J Respir Dis 63 : 380-387, 1982
PubMed
P.205 掲載の参考文献
1) 平林秀樹 気管切開の合併症. 日気食会報 58 : 463-471, 2007
 
2) 山田弘之 宮本朋孝 福家智仁ほか. 気管切開に伴う合併症への対応と回避. 日気食会報 57 : 458-464, 2006
 
3) 小谷治子 日野弘之 小倉英郎ほか. 重症心身障害児 (者) における気管切開の合併症とその対策についての検討. 脳と発達 37 : 473-478, 2005
Medical*Online
P.210 掲載の参考文献
1) 日本気胸・嚢胞性肺疾患学会, 編. 気胸・嚢胞性肺疾患 規約・用語・ガイドライン, 金原出版 : 2009
 
2) 坊垣昌彦 垂井薫 斎藤邦昭ほか. 経皮的気管切開後のカニューレ再挿入時に生じた緊張性気胸. 麻酔 55 (5) : 626-629, 2006
 
3) Fikkers BG, vanVeen JA, Kooloos JG, et al. Emphysema and pneumothorax after percutaneous tracheostomy : case reports an anatomic study. Ohest 125 : 1805-1814, 2004
 
4) 赤松繁 仁田豊生 寺澤悦司ほか, 経皮的気管切開後に発症した縦隔気腫と両側気胸, 日救医 14 : 267-272, 2003
 
5) Takahashi S, Yokoyama T, Ninomiya N, et al. A case Simulyaneous Bilateral Spontaneous pneumothorax Developed into Tension Pneumothorax. J Nippon Med Sch 73 (1) : 29-32, 2006
PubMed
6) Graf-Deuel E, Knoblauch A. Simultaneous Bilateral Spontaneous Pneumothorax. Chest 105 : 1142-1146, 1994
PubMed
7) 根井貴仁 茂木孝 重盛明子ほか. 緊張性気胸様変化を呈した肺気腫・巨大肺嚢胞の1例. THE LUNG eperspectives 13 (3) : 222-226, 2005
 
8) 齋藤美香 鈴木光幸 菊池健二郎ほか. 緊張性気胸との診断にて救急搬送された肺葉性肺気腫の1例, 小児科臨床 60 (7) : 1620-1624, 2007
Medical*Online
9) 安達普至 石橋晋, 胸腔穿刺と胸腔ドレナージ. 外科治療 94 : 494-499, 2006
 
10) Hsu NY, Shin CS, Hsu CP, et al. Spontaneous Hemopneumothorax revisited : Clinical approach and systemic review of the literature. Ann Thorac Surg 80 : 1859-1863, 2005
 
11) 高田宗尚 矢鋪憲功 斉藤裕. 緊張性気胸の胸腔ドレーン後に血胸を合併した1例. 日胸 66 (2) : 167-171, 2007
 
12) 藤森賢 濱本篤 朴在善ほか. 細径光学視管を用いた自然気胸に対する胸腔鏡下手術の検討. 日気嚢疾会誌 6 : 44-46, 2004
 
P.214 掲載の参考文献
1) 日本気胸・嚢胞性肺疾患学会編, 気胸・嚢胞性疾患規約・用語・ガイドライン, 第1版, 金原出版. 東京 : 2009
 
2) 岩崎昭憲 山本聡. 気胸に関する胸腔鏡手術のガイドライン : 内視鏡外科診療ガイドライン 2008年度版 (日本内視鏡学会編), 金原出版. 東京 : 2008
 
3) Takahashi S, Yokoyama T, Ninomiya N, Yokota H, Yamamoto Y. A case of Simultaneous Bilateral Spontaneous Pneumothorax Developed into Tension Pneumothorax. J Nippon Med Sch 73 : 29-32, 2006
 
4) Kwon JB, Choi SY, Kim CK, Park CB. Reexpansion pulmonary edema after treatment of simultaneous bilateral spontaneous tension pneumothorax. J cardiothoracic surg 8 : 62-64, 2013
 
5) Macduff A, Arnold A, Harvey J. BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax : British Thoracic Society Pleural Disease Guideline 2010. Thorac 65 (supple) : 18-31, 2010
 
6) Bense L, Eklund G, Aiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 92 : 1009-1012, 1978
 
7) 青山徹 前原孝光 安藤耕平 益田宗孝. 両側自然気胸の臨床経過および手術適応の検討. 日呼外会誌 24 (4) : 670-673, 20] 0
 
8) 長坂不二夫 大森一光 北村一雄ほか, 異時両側気胸の臨床経過に関する検討. 日臨外会誌 63 : 7-10, 2002
 
9) 三浦弘之 平良修 田口史子 加藤治文. 両側自然気胸の手術適応に関する検討. 日臨外会誌 60 : 1721-1725, 1999
 
10) 門倉光隆 谷尾昇 野中誠ほか. 両側自然気胸症例の検討. 日呼外会誌 6 : 536-542, 1992
 
11) Lee SC, Cheng YL, Tzao C, Hsu HH, Chang H. Simultaneous bilateral primary spontaneous pneumothorax. Respiratology 13 : 145-148, 2008
 
12) Rim T, Bae JS, Yuk YS. Life-Threatening Simultaneous Bilateral Spontaneous Tension Pneumothorax. Korean J Thorac Cardiovasc Surg 44 : 253-256, 2011
PubMed
13) Graf-Deuel E, Knoblauch A. Simultaneous bilateral spontaneous pneumothorax. Chest 105 : 1142-1146, 1994
PubMed
14) 太田英樹 河合秀樹 小川純一. 両側自然気胸術後再発の検討. 日呼外会誌 23 (5) : 686-691, 2009
 
15) Haung TW, Lee SC, Cheng YL, Tzao C, Hsu HH, Chang H, Chen JC, Contralateral recurrence of primary spontaneous pneumothorax. Chest 132 : 1146-1150, 2007
 
16) 近藤 薫 浦上年彦 春日井敏夫 加藤譲司. 両側自然気胸手術症例の臨床的検討. 日呼外会誌 11 : 699-703, 1997
 
17) Sunam G, Gok M, Ceran S, Solak H. Bilateral Pneumothorax : A retrospective Analysis of 40 patients. Surg Today 34 : 817-821, 2004
PubMed
18) Hata Y, et al. Simultaneous bilateral spontaneous pneumothorax with congenital pleuro-pleural Communication. J thorac Dis 5 (1) : 87-89, 2013
PubMed
19) Kircher LT Jr, Schwartzel RL. Spontaneous pneumothorax and its treatment. J Am Med Assoc 155 : 24-29, 1954
 
20) 本間日臣. 自然気胸の内科的治療. 日胸 27 : 453-460, 1968
 
21) 大畑正昭. 自然気胸, 克誠堂 : 1982
 
22) 北村一雄 大畑正昭 奈良田光男ほか. 両側自然気胸に対する外科療法. 日胸外科会誌 37 (1) : 117-122, 1989
 
23) Barker A, Maratos EC, Edmonds L, Lim E. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothorax : a systematic review of randomized and non-randomized trials. Lancet 370 : 329-335, 2007
PubMed
24) Nakazawa K, Ohara G, Kagohashi K, et al. Spontaneous contralateral pneumothorax in a patient with low Body Mass lndex. Cent Eur J Med 7 (6) : 733-735, 2012
 
25) 池田道昭 宇野 顕 菅間啓治 谷田達男 萩原 昇. 一側自然気胸に対する両側同時開胸術-特に, 対側気胸発症率からみた手術適応について. 日胸外会誌 33 : 277-282, 1985
 
26) Chou SH, Li HP, Lee JY, Chang SJ, Lee YL Chang YT, Kao EL, Dai ZK, Huang MF. Is prophylactic treatment of contralateral blebs in patients with primary spontaneous pneumothorax indicated? J thorac Cardiovasc Surg 139 : 1241-1245, 2010
PubMed
P.220 掲載の参考文献
1) 日本呼吸器学会COPDガイドライン作成委員会, COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第4版, メディカルレビュー社, 東京 : 2013
 
2) O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease, Am J Respir Crit Care Med 164 : 770-777, 2001
PubMed
3) O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 64 : 216-223, 2009
 
4) Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311 : 421-425, 1984
PubMed
5) Kitaguchi Y, Fujimoto K, Komatsu Y, Hanaoka M, Honda T, Kubo K. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators. Respir Med 107 : 394-400, 2013
PubMed
6) Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 : 972-977. 2005
PubMed
7) Garcia-Rio F, Rojo B, Casitas R. Lores V, Madero R, Romero D, Galera R, Villasante C, Prognostic value of the objective measurement of daily physical activiAty in patients with COPD. Ohest 142 : 338-346, 2012
PubMed
8) Minakata Y, Sugino A, Kanda M, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Sugiura H, Matsunaga K, Ichinose M. Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease. Respiratory investigation 52 : 41-48. 2014
PubMed
9) 本多雄一 南方良章 杉野亮 神田匡兄 松永和人 田島文博 一ノ瀬正和, 短時間作用型β2刺激薬による慢性閉塞性肺疾患患者の運動耐容能改善効果と改善寄与因子. 呼吸 31 : 1058-1064, 2012
Medical*Online
10) 南方良章. COPD患者の日常活動性評価. 呼吸 31 (11) : 977-983, 2012
Medical*Online
11) Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177 : 622-629, 2008
 
12) Sukisaki T, Senjyu H, Oishi K, Rikitomi N, Ariyoshi K. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD. Physiotherapy theory and practice 24 : 255-263, 2008
 
13) 松永和人 一ノ瀬正和 亀井雅 坂本幸裕 早田敦志 赤松啓一郎 平野綱彦. COPDにおけるmMRCスコアと閉塞性換気障害による病期分類との関連性, 呼吸 33 : 173-178, 2014
 

VIII. 呼吸器・神経系機能異常

P.225 掲載の参考文献
1) 嚥下性肺疾患研究会, 編. 嚥下性肺疾患の診断と治療. ファイザー, 東京 : 2003
 
2) 山中昇. 呼吸細気管支領域の特殊性とその病変の成り立ち. 日本臨床 36 : 2427-2433, 1978
 
3) 福地義之助ほか. びまん性嚥下性細気管支炎の臨床. 日本胸部疾患学会誌 27 : 571-577, 1989
 
4) Mukhopadhyay S, Katzenstein AL. Pulmonary disease due to aspiration of food and other particulate matter : a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol 31 : 752-759, 2007
PubMed
5) Sato K, Nakashima T. Human adult deglutition during sleep. Am Otol Rhinol Laryngol 115 : 334-339, 2006
 
6) Teramoto S, et al. Diffuse aspiration bronchiolitis due to achalasia. Chest 125 : 349-350, 2004
PubMed
7) 須藤英一ほか, 塩酸微量反復注入動物モデルによるびまん性嚥下性細気管支炎に関する実験的検討. 日本老年医学会雑誌 31 : 435-440, 1994
 
8) 野間恵之ほか. びまん性誤嚥性細気管支炎 (DAB : diffuse aspiration bronchiolitis) のHRCT像. 臨床放射線 41 : 129-133, 1996
 
9) Teramoto S, et al. Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 353 : 1243, 1999
PubMed
10) Takeshi M, et al. Importance of Diffuse Aspiration Bronchiolitis Caused by Chronic Occult Aspiration in the Elderly. Chest 110 : 1289-1293, 1996
 
11) 井上哲郎ほか. 輪状咽頭筋切断術が有効であった, びまん性嚥下性細気管支炎 (DAB) と考えられる1例. 日本胸部疾患学会誌 34 : 926-929, 1996
 
12) Ebihara T, Takahashi H, et al. Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc 53 : 824-828, 2005
 
13) Arai T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 64 : 573-574, 2005
PubMed
14) Shinohara Y. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis 22. 57-60, 2006
PubMed
P.228 掲載の参考文献
1) Graham GR, Hill DW, Hunn JF. Die Wirkung hoher CO2-Konzentrationen auf Kreislauf und Atmung. Anaesthesist 9 : 70-74, 1960
 
2) Kilburn KH. Neurologic manifestation of respiratory failure. Arch Int Med 116 : 409-415, 1965
 
3) Sleker HO, Hickam JB. Carbon dioxide intoxication : clinical syndrome, its etiology and management, with particular reference to the use of mechanical respirators. Medicine 35 : 389-423, 1956
 
4) Aubier M, Murciano D, Milic-Emili J, Touaty E, Daghfous J, Pariente R, Derenne JP. Effects of the administration of O2 on ventilation and blood gases during acute respiratory failure. Am Rev Respir Dis 122 : 747-754, 1980
PubMed
5) Pollock JM, Deiber AR, Whitlow CT. Hypercapnia-induced cerebral hyperperfusion : an unrecognized clinical entity. Am J Neuroradiol 30 : 378-385, 2009
 
6) Thakur N, Blanc PD, Julian LJ, et al. COPD and cognitive impairment : the role of hypoxemia and oxygen therapy. Intrernat J COPD 263-269, 2010
PubMed
7) Cross RL, Kumar R, Macey PM, et al. Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep 31 : 1103-1109, 2008
PubMed
8) Bailey DM, Bartsch P, Knauth M, et al. Emeerging concepts in acute mountain sickness and high-altitude cerebral edema : from molecular to the morphological, Cell Mol Life Sci 66 : 3583-3594, 2009
 
9) Pavlicek V, Schirlo C, Nebel A, et al. Cognitive and emotional processing at high altitude. Aviation. Space and Environmental Med 76 : 28-33, 2005
 
10) Dodd JW, Chung AW, van den Broek MD, et al. Brain structure and function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186 (3). 240-245, 2012
PubMed
11) Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 35 : 913-922, 2010
PubMed
P.232 掲載の参考文献
1) 二瓶義廣 伊東大介 鈴木則宏. 家族性ALSと孤発例ALS発症関連遺伝子オーバービュー, Clinical Neurosci 29 : 1015-1018, 2011
 
2) 熱田直樹 祖父江元. 孤発例ALSの疫学, Clinical Neurosci 26 : 266-267, 2008
 
3) Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis : new evidence and unsolved issues. J Neurol Neurosurg Pshchiatry 79 : 6-11, 2008
 
4) 寺尾心 三浦尚文 小佐野裕ほか. 高齢発症の筋萎縮性側索硬化症患者の臨床特徴 ; とくに呼吸不全との関連について. 臨床神経 46 : 381-389, 2006
 
5) Bunina TL. On intracellular inclusions in familial amyotrophic lateral sclerosis. Korsak of J Neuropathol Psychiatry 62 : 1293, 1962
 
6) 熱田直樹 祖父江元. ALSの治療とケア, 治験の現状と今後の展望. Clinical Neurosci 29 : 1060-1061, 2011
 
7) Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole : Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 49 : 657-659, 1997
 
8) From GB, Wisdom PJ, Block AJ. Amyotrophic lateral sclerosis presenting with respiratory failure : Diaphragmatic paraiysis and dependence on mechanical ventilation in two patients. Chest 71 : 612-614, 1977
 
9) 伊藤和彦 牧野真人. 急性呼吸不全として人工呼吸器管理後, 筋委縮性側索硬化症と診断された2例. 日呼吸会誌 42 : 645-648, 2004
 
10) 清水浩一 西森茂樹 本間正人ほか. 呼吸不全を主訴とした筋萎縮性側索硬化症の1例. 臨床麻酔 25 : 1631-1632, 2001
 
11) 竹川英宏 山崎薫九 國分則人ほか. 呼吸筋麻痺で発症した筋萎縮性側索硬化症の一例, 内科 91 : 967-969, 2003
 
12) 内田祐司 松浦甲彰 中村燈喜ほか. 呼吸筋麻痺を主症状とした筋萎縮性側索硬化症の1例. 臨床麻酔 25 : 1631-1632, 2001
 
13) 山中真波 錦織朋之 橋本圭司. ベクロニウムの作用延長を契機に診断された筋萎縮性側索硬化症の1例. 臨床麻酔 19 : 107-108, 1995
 
14) 関匡彦 小延俊文 渡辺知朗ほか, 心肺停止を主訴として発見された筋萎縮性側索硬化症の1例. 救急医学 34 : 119-121, 2010
 
15) Corcia P, Petiot P, Stevic Z, et al. Respiratory onset in an ALS family with L144F SOD1 mutation. J Neurol Neurosurg Psychiatry 82 : 747-749, 2009
 
16) Shoesmith CL, Findlater K, Rowe A, Strong MJ, Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 45 : 629-631, 2006
 
17) Varato J, Siderowl A, Damiano P, et al. Postural change of forced vital capacity predicts some respiratory symptoms in ALS, Neurology 57 : 357-359, 2001
 
18) De Carvalho M, Matias T, Coeho F, et al. Motor neuron disease presenting with respiratory failure, J Neurolsci 139 (Suppl) : 117-122, 1996
 
19) Meyrignac C, Poirier J, Degos JD. Amyotrophic lateral sclerosis presenting with respiratory insufficiency as the primary complaint : clinicopathological study of a case. Eur Neurol 24 : 115-120, 1985
PubMed
20) 朱段浩 秋山修 折津愈ほか. 両側性の非弛緩性横隔膜麻痺で発症し, 呼吸不全で死亡した筋萎縮性側索硬化症の1剖検例. 日胸 53 : 438-354, 1994
 
21) Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease. COPD and nocturnal hypoventilation-A consensus conference report. Chest 116 : 521-534, 1999
PubMed
22) Miiler RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update : the care of the patient with amyotrophic iateral sclerosis : drug, nutrition, and respiratory therapies. Neurology 73 : 1218-1226, 2009
 
23) ALS治療ガイドライン, 日本神経学会治療ガイドライン 2002 (http://www.neurology-jp.org/guidelinem/pdf/als_09.pdf)
 
24) 園田至人, 神経疾患の診断・治療・予防に関する包括的臨床研究-肺内パーカッションベンチレーター (IPV) による神経難病患者の呼吸器感染症の予防と治療に関する検討-. 神経疾患の診断・治療・予防に関する包括的臨床研究平成18-20年度総括研究報告書 : 103-105, 2009
 
P.236 掲載の参考文献
1) Shiba K, Isono S, Sekita Y, et al. Inspiratory activation of the vocal cord adductor, part I : human study in patients with restricted abduction of the vocal cords. Laryngoscope 114 : 372-375, 2004
 
2) Buddiga P, et al. Vocal Cord Dysfunction. : 2011 (http://emedicine.medscape.com)
 
3) Kenn K, Balkissoon R. Vocal cord dysfunction : what do we know? Eur Respir J 37 : 194-200, 2011
PubMed
4) Vertigan AE, Theodoros DG, Gibson PG, et al, The relationship between chronic cough and paradoxical vocal fold movement : a review of the literature. J Voice 20 : 466-480, 2006
PubMed
5) Deckert J, Deckert L. Vocal cord dysfunction. Am Fam Physiciar? 81 : 156-159, 2010
PubMed
6) Morris MJ, Christopher KL. Diagnostic criteria for the classification of vocal cord dysfunction. Chest 138 : 1213-1223, 2010
PubMed
7) Christopher KL, Wood RP 2 nd. Eckert RC, et al. Vocal-cord dysfunction presenting as asthma, N Engl J Med 308 : 1566-1570, 1983
 
8) Doshi DR, Weinberger MM. Long-term outcome of vocal cord dysfunction. Ann Allergy Asthma Immunol 96 : 794-799, 2006
PubMed
P.240 掲載の参考文献
1) Kahn A, Groswasser J, Franco P, et al. Sleep and cardlorespiratory characteristics of infant victims of sudden death : a prospective case-control study. Sleep 15 : 287-292, 1992
PubMed
2) Kato I, Groswasser J, Franco P, et al. Developmental characterlstlcs of apnea in infants who succumb to sudden infant death syndrome. Am J Respir Crit Care Med 164 : 1464-1469, 2001
PubMed
3) Kato I, Franco P, Groswasser J, et al. Incomplete arousal processes in infants who were victims of sudden death. Am J Respir Crit Care Med 168 : 1298-1303, 2003
PubMed
4) 磯野史朗. 乳児の気道閉塞性評価 : そこから見えてくるSIDSの病態生理. 日本SIDS学会雑誌 9 : 3-9, 2009
Medical*Online
5) Isono S. Developmental changes of pharyngeal airway patency : implications for pediatric anesthesia. Paediatr Anaesth 16 : 109-122, 2006
PubMed
6) Wheatley JR, Tangel DJ, Mezzanotte WS, et al. Influence of sleep on response to negative airway pressure of tensor palatine muscle and retropalatal airway, J Appl Physiol 75 : 2117-2124, 1993
PubMed
7) Gauda EB, Miller MJ, Carlo WA, et al. Genioglossus response to airway occlusion in apneic versus nonapneic infants. 22 : 683-687, 1987
PubMed
8) Isono S, Tanaka A, Ishikawa T, Developmental changes in collapsibility of the passive pharynx during infancy. Am J Respir Crot Care Med 162 : 832-836, 2000
 
9) Isono S, Remmers JE, Tanaka A, et al. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects, J Appl Physiol 82 : 1319-1326, 1997
PubMed
10) Watanabe T, Isono S, Tanaka A, et el. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing. Am J Respir Crit Care Med 165 : 260-265, 2002
 
11) Rees K, Wright A, Keeling JW, et al. Facial structure in the sudden infant death syndrome : case-control study, BMJ 317 : 179-180, 1998
PubMed
12) Siebert JR, Haas JE. Enlargement of the tongue in sudden infant death syndrome. Pediatr Pathot 11 : 813-826, 1991
PubMed
13) Horn MH, Kinnamon DD, Ferraro N, et al. Smaller mandibular size in infants with a history of an apparent life-threatening event. J Pediatr 149 : 499-504, 2006
PubMed
14) Johnston RV, Grant DA, Wlkinson MH, et al. Repetitive hypoxia rapidly depresses arousal from active sleep in newborn lambs. J Physiol 510 : 651-659, 1998
 
15) Katz-Salamon M. Delayed chemoreceptor responses in infants with apnoea. Arch Dis Child 89 : 261-266, 2004
PubMed
16) Lewis KW, Bosque EM. Deficient hypoxia awakening response in infants of smoking mothers : possible relationship to sudden infant death syndrome. J Pediatr 127 : 691-699, 1995
PubMed
17) Perrin DG, Cutz E, Becker LE, et al. Sudden infant death syndrome : increased carotid-body dopamine and noradrenaline content. Lancet 2 (8402) : 535-537, 1984
PubMed
18) Harrington C, Kirjavainen T, Teng A, et al. Altered autonomic function and reduced arousability in apparent life-threatening event infants with obstructive sleep apnea. Am J Respir Crit Care Med 165 : 1048-1054, 2002
PubMed
19) Pereira KD, Rathi NK, Fatakia A, et al. Body position and obstructive sleep apnea in 8-12-month-old infants. Int J Pediatr Otorhinolaryngol 72 : 897-900, 2008
PubMed
20) Waters KA, Gonzalez A, Jean C, et al. Face-straight-down and face-near-straight-down positions in healthy, prone-sleeping infants. J Pediatr 128 : 616-625, 1996
PubMed
21) Ishikawa T, Isono S, Aiba J, et al. Prone position increases collapsibility of the passive pharynx in infants and small children. Am J Respir Crit Care Med 166 : 760-764, 2002
PubMed
22) Franco P, Pardou A, Hassid S, et al. Auditory arousal thresholds are higher when infants sleep in the prone position. J Pediatr 132 : 240-243, 1998
PubMed
23) Rambaud C, Guilleminault C. "Back to sleep" and unexplained death in infants. Sleep 27 : 1359-1366, 2004
PubMed
P.247 掲載の参考文献
1) American Academy of Sleep Medicine. In : The International Classification of Sleep Disorders (2nd ed), Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester : 2005
 
2) Ozaki A, Inoue Y, Nakajima T, et al. Health-related quality of life among drug-naive patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time. J Clin Sleep Med 4 : 572-578, 2008
PubMed
3) Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice : moleculargenetics of sleep regulation. Cell 98 : 437-451, 1999
 
4) Lin L, Faraco J, Li R, Kadotani H, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (3) : 365-376, 1999
PubMed
5) Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (9197) : 39-40, 2000
PubMed
6) Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy, Neuron 27 : 469-474, 2000
PubMed
7) Peyron C, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18 : 9996-10015, 1998
PubMed
8) Juji T, Satake M, Honda Y, et al. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24 : 316-319, 1984
 
9) Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68 (3) : 686-699, 2001
PubMed
10) Ohayon MM, Priest RG, Zulley J, et al. Prevalence of narcolepsy symptomatology and diagnosis inthe European general population. Neurology 58 : 1826-1833, 2002
 
11) Honda Y, Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa City. Sleep Res 8 : 191, 1979
 
12) Broughton WA, Broughton RJ. Psychosocial impact of narcolepsy. Sleep 17 : S45-S49, 1994
PubMed
13) Plazzi G, Serra L, Ferri R. Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev 12 : 109-128, 2008
PubMed
14) Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 : 1553-1562, 2002
PubMed
15) Sasai T, 1noue Y, Komada Y, et al. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1*1501/DQB1*0602 finding. Sleep Med 10 : 961-966, 2009
 
16) Inoue Y, Nanba K, Higami S, etet, Clinical significance of sleep-related breathing disorder in narcolepsy. Psychiatry Clin Neuroscl 56 : 269-270, 2002
 
17) US Modafinil in Narcolepsy Multicenter Study Group : Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy : US Modafinil in Narcolepsy Muiticenter Study Group. Neurology 54 : 1166-1175, 2000
 

IX. 他臓器疾患の併存

P.255 掲載の参考文献
1) 日本透析医学会 統計調査委員会. 図説 わが国の慢性透析療法の現況 2013年12月31日現在, 社団法人日本透析医学会, 東京 : 2013
 
2) 樋口千恵子 佐中孜. 腎と透析 68 (5) : 605-609, 2010
 
3) 坂東政司 杉山幸比古, 呼吸器疾患診療マニュアル 呼吸器疾患の治療尿毒症および透析に伴う呼吸器疾患, 日医師会誌 137 (特別 2) : S288-S289, 2008
 
4) 石黒望. V. 維持血液透析療法 慢性腎不全 導入時に合併症を伴った症例への対策慢性腎不全における呼吸器合併症. 日臨 62 (増刊号 6) : 62-65, 2004
 
5) フレイザー RS, コールマン N, ミュラー NL, パレ PD, 編著, 第14章 肺水腫 : 清水英治 藤田次郎, 監訳, フレイザー呼吸器病学エッセンス, 西村書店. 東京 : pp665-689, 2009
 
6) Jarratt MJ, Sahn SA. Pleural effusions in hospitalized patients receMng long-term hemodialysis. Chest 108 (2) : 470-474, 1995
PubMed
7) Bakirci T, Sasak G, Ozturk S, et al. Pleural effusion in long-term hemodialysis patients. Transplant Proc 39 (4) : 889-891, 2007
PubMed
8) Hopps HC, Wissler RW, Uremic pneumonitis. Am J Pathol 31 (2) : 261-273, 1955
PubMed
9) Berger HW, Rammohan G, Neff MS, et al. Uremic pleural effusion. A study in 14 patients on chronic dialysis. Ann Intern Med 82 (3) : 362-364, 1975
PubMed
10) 日本呼吸器学会「医療・介護関連肺炎 (NHCAP) 診療ガイドライン作成委員会」編, 医療・介護関連肺炎ガイドライン, 社団法人日本呼吸器学会, 東京 : 2012
 
11) 日本呼吸器学会「呼吸器感染症に関するガイドライン作成委員会」, 編, 成人院内肺炎診療ガイドライン, 社団法人日本呼吸器学会. 東京 : 2008
 
12) 徳山清之 井関邦敏. 沖縄県における (新型) インフルエンザ罹患状況. 日透会誌 43 (Suppl 1) : 551, 2010
 
13) 安藤亮一 杉崎弘章 吉田雅治ほか. 東京都多摩地区における新型インフルエンザの発生状況に関する検討. 日透会誌 43 (Suppl, 1) : 550-, 2010
 
14) 浅野学 関□嘉 岩渕仁ほか. 血液透析患者に発生したレジオネラ肺炎の1例. 透析会誌 37 (5) : 1317-1321, 2004
 
15) 井上剛 中村太一 片桐大輔ほか. 透析患者の結核補助診断におけるQuantiFERON TB-2Gの有用性について. 透析会誌 41 (1) : 65-70, 2008
 
16) Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 39 (5) : 1011-1017, 2002
PubMed
17) Calvert AH. A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel. Semin Oncol 24 (1 Suppl 2) : S2-85-S2-90, 1997
 
18) Rosell R, Gatzemeier U, Betticher DC, et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer : a cooperative multinational trial. Ann Oncot 13 (10) : 1539-1549, 2002
PubMed
19) Shinagawa N, Yamazaki K, Asahina H, et al. Gefitinib administration in a patient with lung cancer undergoing hemodialysis. Lung Cancer 58 (3) : 422-424, 2007
 
20) Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 7 : 131-143, 2003
PubMed
P.259 掲載の参考文献
1) Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med 358 : 2378-2387, 2008
PubMed
2) 勝田悌実 古明地弘和 清水秀治. 肝肺症候群. 治療学 41 : 377-381, 2007
Medical*Online
3) Poterucha JJ, Krowka MJ, Dickson ER, et al. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 21 : 96-100, 1995
PubMed
4) Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome : Impact of liver transplantation. Hepatology 41 : 1122-1129, 2005
PubMed
5) Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 24 : 861-880, 2004
PubMed
6) Martinez G, Barbera JA, Navasa M, et al, Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 30 : 882-889, 1999
 
7) Najafi Sani M, Kianifar HR, Kianee A, et al. Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome. World J Gastroenterol 12 : 2427-2431, 2006
PubMed
8) Rabiller A, Nunes H, Lebrec D, et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 166 : 514-517, 2002
PubMed
9) Lasch HM, Fried MW, Zacks SL, et al, Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 7 : 147-149, 2001
 
10) Martinez-Palli G, Drake BB, Garcia-Pagan JC, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol 11 : 6858-6862, 2005
PubMed
11) Schiffer E, Majno P, Mentha G, et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation : a prospective study in 90 patients. Am J Transplant 6 : 1430-1437, 2006
PubMed
P.263 掲載の参考文献
1) Seeley EJ. Update in the management of acute lung injury : a focus on the overlap between AKI and ARDS. Adv Chronic Kidney Dis 20 : 14-20, 2013
PubMed
2) 大串文隆 小倉剛. 各種疾患にみられる呼吸器病変 尿毒症肺. 別冊日本臨床 領域別症候群 4 呼吸器症候群 (下巻) 770-773, 1994
 
3) 上甲隆敏 平方英樹. 腎不全 尿毒症肺. 別冊日本臨床 腎臓病症候群 (上巻) 69-71, 1997
 
4) Rackow EC, Fein IA, Sprung C, et al. Uremic pulmonary edema. Am J Med 64 : 1084-1088, 1978
PubMed
5) Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis 15 : 284-296, 2008
PubMed
6) 湯沢由紀夫 林宏樹. AKI・急性腎不全の予防と治療. 日腎会誌 52 : 553-557, 2010
 
7) Scheel PJ, Liu M, Rabb H. Uremlc lung : new insights into a forgotten condition. Kidney Int 74 : 849-851, 2008
PubMed
8) Doi K, Ishizu T, Fujita T, et al. Lung injury following acute kidney injury : kidney-lung crosstalk. Clin Exp Nephrol. 15 : 464-470, 2011
PubMed
9) 湯澤由紀夫 林宏樹. 全身性疾患と腎障害 肺・腎連関. Annual Review腎臓 2012 : 140-149, 2012
 
10) Perna AF, Luciano MG, Ingrosso D, et al. Hydrogen sulphide-generating pathways in haemodialysis patients : a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 24 : 3756-3763, 2009
 
11) Hobo A, Yuzawa Y, Kosugi T, et al. The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest 119 : 1616-1625, 2009
PubMed
12) Bachofen H, Weibel ER. Uremic pulmonary edema : Hasleton PS, 5th ed, In Spencer's Pathology of the Lung, McGraw-Hill. New York : pp720-721, 1996
 
13) Gavelli, Zompatori M. Thoratic complications in uremic patients and in patients undergoing dialytic treatment : state of art. Eur Radiol 7 : 708-717, 1997
 
14) Facer RG, et al. Pulmonary hypertension and edema : Facer RG, eds, In Diagnosis of Disease of the Chest, WB Saunders. Philadelphia : pp1917-1920, 1990
 
15) Storto ML, Kee ST, Golden JA, et al. Hydrostatic pulmonary edema : high-resolution CT findings. AJR 165 : 817-820, 1995
PubMed

X. その他

P.270 掲載の参考文献
1) Shimura S, Sasaki T, Sasaki H, Takishima T. Chemical properties of bronchorrhoea sputum in bronchial asthma. Chest 94 : 1211-1215, 1988
PubMed
2) Shimura S, Sasaki T, Sasaki H, Takishima T, Umeya K. Viscoelastic properties of bronchorrhoea sputum in bronchial asthmatics. Blorheology 25 : 173-179, 1988
PubMed
3) Honda I, Shimura S, Sasaki T, Sasaki H, Takishima T, Nakamura M. Airway mucosal permeability in chronic bronchitis and bronchial asthmatics. Am Rev Respir Dis 137 : 866-871, 1988
PubMed
4) Shimura S. Signal transduction in mucous secretion by bronchial gland cells. Cellular Signalling 2 : 45-55, 2000
 
5) Shimura S, Takishima T. Airway submucosal secretion. In : Airway Secretion : Physiological bases for control of mucous hypersecretion, Takishima T and Shimura S, eds. Marcel Dekker Inc. : pp325-398, 1994
 
6) Sasamori K, Sasaki T, Takasawa S, Tamada T, Nara M, Irokawa T, Shimura S, Shirato K, Hattori T. Cyclic ADP-ribose, a putative Ca2+ mobilizing second messenger, operates in airway gland acinar cells, Am J Physiol 287 : L69-78, 2004
 
7) Shimura S. Extracellular ATP regulation of airway secretion. Drug Development Research 52 : 170-177, 2001
 
8) Dulfano M, Luk CK. Sputum and ciliary inhibition in asthma. Thorax 37 : 646-651, 1982
PubMed
9) Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 101 : 916-921, 1992
PubMed
10) Chen TM, Dulfano MJ. Mucus viscoelasticity and mucociliary transport rate, J Clin Lab Med 91 : 423-431, 1978
 
11) Keizer RJ, Beijnen JH, Baas P. Flooding of the lungs and severe dyspnea in a patient with bronchoalveolar carcinoma. 」Oncol Pharm Pract 17 : 270-273, 2011
 
12) Takao M, Takagi T, Suzuki H, Shimamoto A, Murashima S, Taguchi O, Shimpo H. Resection of mucinous lung adenocarcinoma presenting with intractable bronchorrhea. J Thorac Oncol 5 : 576-578, 2010
PubMed
13) Wislez M, Massiani MA, Milleron B, Souidi A, Carette MF, Antoine M, Cardranel J. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest 123 : 1868-1877, 2003
 
14) Homma S, Kawabata M, Kishi K, Tuboi E, Narui K, Nakatani T, Nakata K. Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma. Chest 115 : 1465-1468, 1999
 
15) Tamaoki J, Kohri K, Isono K, Nagai A. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma : role of cyclooxygenase. Chest 117 : 1213-1214, 2000
PubMed
16) Nakajima T, Terashima T, Nishida J, Onoda M, Koide O. Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9. Internal Medicine 541 : 225-228, 2002
 
17) Takno M, Inoue K, Watanabe F, Onoda K, Shimono T, Shimpo H, Yada I, Successful treatment of peristent bronchorrhea by gefitinib in a case with recurrent bronchioloalveolar carcinoma : a case report. World J Surg Oncol 1 : 8, 2003
 
18) 丁akeyama K, Dabbagh K, Lee HM, Aguti C, Lausier JA, Ueki IF, Grattan KM, Nadel JA. Epidermal growth factor system muin production in airways, Proc Natl Acad Sci USA 16 : 3081-3086, 1999
 
19) Shimura S, Takishima T. Bronchorrhea from diffuse lymphangitic metastasis of colon carcinoma to the lung. Chest 105 : 308-310, 1994
 
20) Epaulard O, Moro D, Langin T, Devouasoux G, Brambilla C. Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung. Lung Cancer 2-3 : 331-334, 2011
 
21) Evner CI, Ayala GU. Organophosphate and carbamate intoxication in La Paz, Bolivia. J Emerg Med 36 : 348-352, 2008
 
22) Guzman CA. Excerbation of bronchorrhea induced by topical timolol. Am Rev Respir Dis 121 : 899-900, 1980
 
23) Hayashi H, Aoshima T, Otani K. Malignant catatonia with severe bronchorrhea and its response to electroconvulsive therapy. Prog Neuropsychopharmacol Biol Psychiatry 30 : 310-3011, 2006
PubMed
24) Mallet P, Mourdi N, Dubus JC, Bavoux F, Boyer-Gervoise MJ, Jean-Pastor MJ, Chalumeau M. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients : A National Servey. PLoS ONE 6 : e22792, 2011
 
25) So SY, Lam WK, Sham MK. Bronchorrhea. A presenting feature of active endobronchial tuberculosis, Chest 84 : 635-638, 1983
PubMed
P.273 掲載の参考文献
1) Hanke R, Kretzschmar R. Round atelectasis. Semin Roentgenol 15 : 174-182, 1980
PubMed
2) 須甲憲明 川上義和. 円形無気肺 : 上銘外喜夫, 編. 呼吸器症候群, 日本臨牀社, 大阪 : pp284-286, 1994
 
3) Fraser RS, Muller NL, Colman N, et al. Round atelectasis : Diagnosis of Diseases of the Chest, 4th ed. WB Saunders, Philadelphia : pp521-522, 1998
 
4) 森雅一. 胸水貯留に伴う末梢性無気肺のCT像-円形無気肺の成立機序に関連して-. 日本医放会誌 54 : 399-409, 1994
 
5) Menzies R, Fraser R. Round stelectasis. Pathologic and pathogenetic features. Am J Surg Pathol 11 : 674-681, 1987
PubMed
6) Schneider HJ, Felson B, Gonzalez LL. Rounded atelectasis. AJR 134 : 225-232, 1980
PubMed
7) Nakagawa Y, Shimazu K, Ebihara M, et al. Rounded Atelectasis that Disappeared after Bronchoscopy. Internal Medicine 37 : 870-871, 1998
PubMed
8) Gierade DS, Glazer HS, Slone RM. Pseudomass dus to atelectasis in patients with severe bullous emphysema. AJR 168 : 85-92, 1997
 
9) Stathopoulos GA, Karamessini MT, Sotiriadi AE, et al. Rounded atelectasis of the lung. Respiratory Medicine 99 : 615-623, 2005
 
10) 林邦昭 神崎修一 上谷雅孝ほか, 円形無気肺-特にその幅広いスペクトラムについて-, 日本医放会誌 53 : 1020-1032, 1993
 
11) Hillerdal G. Rounded atelectasis. Clinical experience with 74 patients. Chest 95 : 836-841, 1989
PubMed
12) Batra P, Brown K, Hayashi K, et al. Rounded atelectasis. J Thorac Imaging 11 : 187-197, 1996
PubMed
13) Yamaguchi T, Hayashi K, Ashizawa K, et al. Magnetic resonance imaging of rounded atelectasis. J Thorac Imaging 12 : 188-194, 1997
PubMed
14) 清水道生 伊藤智雄. 知っていると役立つ外科病理の診断クルー-Pleural invagination (folded pleura) in round atelectasis-. 病理と臨床 18 : 680-681, 2000
 
15) Mc Adams HP, Erasmus JJ, Patz EF, et al, Evaluation of patients with round atelectasis using 2- [18F] fluoro-2-deoxy-D-glucose PET, J Oomput Assist Tomogr 22 : 601-604, 1998
 
16) Nakazono T, Nakamura Y, Satoh T, et al. Squamous Cell Carcinoma Coexisting in Rounded Atelectasis : Diagnostic Pitfalls. AJR 182 : 79-80, 2004
PubMed
17) Roviaro GC, Varoli F, Vergani C, et al. State of the art in thoracospic surgery : a personal experience of 2000 videothoracoscopic procedures and an overview of the literature. Surg Endosc 16 (6) : 881-892, 2002
 
P.278 掲載の参考文献
1) Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 258 : 1123-1142, 1958
PubMed
2) Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan, Am J Respir Crit Care Med 177 : 752-762, 2008
PubMed
3) Ishii H, Trapnell BC, Tazawa R, Inoue Y, A kira M, Kogure Y, Tomii K, Takada T, Hojo M, Ichiwata T, Goto H, Nakata K. Comparative study of high-resolution ct findings between autoimmune and secondary pulmonary alveolar proteinosis, Chest 136 : 1348-1355, 2009
 
4) Shoji N, Ito Y, Kimura Y, Nishimaki J, Kuriyama Y, Tauchi T, Yaguchi M, Payzulla D, Ebihara Y, Ohyashiki K. Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes : a report of four cases detected on autopsy. Leuk Res 26 : 591-595, 2002
PubMed
5) Xipell JM, Ham KN, Price CG, Thomas DP. Acute silicoproteinosis. Thorax 32 : 104-111, 1977
PubMed
6) Miller RR, Churg AM, Hutcheon M, Lom S, Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 130 : 312-315, 1984
PubMed
7) Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 181 : 458-464, 2010
PubMed
8) Thind GS. Acute pulmonary alveolar proteinosis due to exposure to cotton dust. Lung India 26 : 152-154, 2009
PubMed
9) Dawkins SA, Gerhard H, Nevin M. Pulmonary alveolar proteinosis : a possible sequel of NO2 exposure. J Occup Med 33 : 638-641, 1991
PubMed
10) Heppleston AG, Wright NA, Stewart JA. Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol 101 : 293-307, 1970
PubMed
11) Ishii H, Tazawa R, Kaneko C, Saraya T, Inoue Y, Hamano E, Kogure Y, Tomii K, Terada M, Takada T, Hojo M, Nishida A, Ichiwata T, Trapnell BC, Goto H, Nakata K. Clinical features of secondary pulmonary alveolar proteinosis : pre-mortem cases in Japan. Eur Respir J 37 : 465-468, 2011
PubMed
12) 石井晴之. 本邦における続発性肺胞蛋白症の予後解析に関する研究. 厚生労働省難治性疾患克服研究事業 難治性希少肺疾患 (肺胞蛋白症, 先天性間質性肺疾患, オスラー病) に関する調査研究 (研究代表者 : 井上義一) 平成24年度総括・分担研究報告書 : pp52-55, 2013
 
13) Ishii H, SeymourJF, Tazawa R, Inoue Y, Uchida N, Nishida A, Kogure Y, Saraya T, Tomii K, Takada T, Itoh Y, Hojo M, Ichiwata T, Goto H, Nakata K. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis : a retrospective cohort study in Japan. BMC Pulm Med 14 : 37, 2014 (doi : 10. 1186/1471-2466-14-37)
 
14) Nishida A, Miyamoto A, Yamamoto H, Uchida N, Izutsu K, Wake A, Ohta Y, Fujii T, Araoka H, Taniguchi S, Kishi K. Possible association of trisomy 8 with secondary pulmonary alveolar proteinosis in myelodysplastic syndrome. Am J Respir Crit Care Med 184 : 279-280, 2011
 
15) Handa T, Nakatsue T, Baba M, Takada T, Nakata K, Ishii H. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behcet's disease. Respir Investig 52 : 75-79, 2014
PubMed
P.283 掲載の参考文献
1) Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cellhistiocytosis, N Engl J Med 342 : 1969-1978, 2000
 
2) Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 27 : 1272-1285, 2006
PubMed
3) Ryu JH, Colby TV, Hartmen TE, et al. Smoking-related interstitial lung diseases : a concise review. Eur Respir J 17 : 122, 2001
 
4) Suri HS, Yi ES, Nowakowski GS, Vassallo R. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis 7 : 16, 2012
PubMed
5) 藤本圭作 久保恵嗣. 若年発症COPD (若年性肺気腫), 肺ランゲルハンス細胞ヒスチオサイトーシス (ヒスチオサイトーシス X), 肺胞低換気症候群に関する全国疫学調査. 平成18年度厚生労働省科学研究費補助難治性疾患克服研究事業報告書 : pp41-42, 2008
 
6) Asamoto H, Kitaichi M, Nagai S, et al. Pulmonary eosinophilic granuloma-clinical analysis of 17 patients. Nihon Kyobu Shikkan Gakkai Zasshi 33 : 1372-1381, 1995
PubMed
7) Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X), Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique de Nord. Eur Respir J 9 : 2002-2006, 1996
 
8) Vassallo R, Ryu JH, Schroeder DR, Decker PA, Umper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 346 : 484-490, 2002
PubMed
9) Watanabe T, Tatsumi K, Hashimoto S, et al. Clinicoepidemiological features of pulmonary histiocytosis X. Intern Med 40 (10) : 998-1003, 2001
 
10) Canuet M, Kessler R, Jeung MY, et al. Correlation between higt-resolution computed tomography findings and lung function in pulmonary langerhans cell histiocytosis. Respiration 74 : 640-646, 2007
 
11) Howarth DM, Gilchrist GS, Mulian BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis : diagnosis, natural history, management, and outcome. Cancer 85 (10) : 2278-2290, 1999
 
12) Webb WR, Muller NL, Naidich DP. Pulmonary Langerhans cell Histiocytosis. In : High-resolution CT of the LUNG, 4th Edition. Lippincott Williams & Wilkins. Philadelphia : pp368-381, 2009
 
13) Auerswald U, Barth J, Magnussen H. Value of CD1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 169 : 305-309, 1991
 
14) Katzenstein A. Langerhans cell Histiocytosis (pulmonary eosinophilic granuloma). In : Surgical Pathology of Non-Neoplastic Lung Disease, 4th Edition, Saunders. Philadelphia : pp417-425, 2006
 
15) Kambouchner M, Basset F, Marchal J, et al. Tree-dimensional characterization of pathologic lesions in Pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 166 : 1483-1490, 2002
 
16) Krajicek BJ, Ryu JH, Hartman TE, et al. Abnormal fluorodeoxyglucose PET in pulmonary langerhans cell histiocytosis. Chest 135 : 1542-1549, 2009
PubMed
17) Tazi A, Marc K, Dominique S, et al. Serial computed tomography and lung function testing in pulmonary langerhans' cell histiocytosis, Eur Respir J 40 : 905-912, 2012
PubMed
18) Le Pavec J, Lorillon G, Jais X, et al. Pulmonary Langerhans cell histiocytosis associated pulmonary hypertension : clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest 142 : 1150-1157, 2012
PubMed
19) Kiakouama L, Cottin V, Etienne-Mastroianni B, et al. Severe pulmonary hypertension in histiocytosis X : long-term improvement with bosentan. Eur Respir J 36 : 202-204, 2010
PubMed
P.288 掲載の参考文献
1) Joseph J, Sahan SA. Thoracic endmetriosis syndrome : new observation from an analysis of 11 cases. Am J Med 100 : 164-170, 1996
 
2) Johnson MM. Catamenial pneumothorax and other thoracic manifestations of endometriosis. Clin Chest Med 25 : 311-319, 2004
PubMed
3) 栗原正利. 気胸の診断と治療 女性気胸 月経随伴性気胸 日本医事新報 4368 : 49-52, 2008
 
4) 栗原正利. 月経随伴性気胸・子宮内膜症性気胸 : 新領域別症候群シリーズ no1 呼吸器症候群 (第2版) III その他の呼吸器疾患を含めて IX胸膜疾患. 日本臨牀社. 大阪 : pp352-354, 2009
 
5) Maurer ER, et al. Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. JAMA 168 : 2013, 1958
 
6) 伴場次郎. 月経随伴生気胸の分類と診断基準. 日胸疾会誌 21 (12) : 1196-1200, 1983
 
7) 柴田紘一郎. 審査的胸腔鏡と生検 : 胸腔鏡手術研究会 : 胸腔鏡アトラス, 金原出版. 東京 : pp 158-162, 1997
 
8) 栗原正利. 横隔膜疾患に対する胸腔鏡下横隔膜切除術, 手術 50 : 2149-2156, 1996
 
9) Meyers AM. Distribution of intra-abdominal malignant seeding. Radiology 119 (1) : 198-206, 1973
 

書評

最近チェックした商品履歴

Loading...